Method for producing substituted derivatives of penem-3-carboxylic acid or tehir esters,or tehir sal

专利摘要:
Antibacterial compounds of formula (I) <IMAGE> (I) wherein, R1' is alkyl or hydroxyalkyl; R2 is hydrogen or a carboxy protecting group; and Y' is a group-S-heterocyclic or pyridyl, which group may be substituted, and pharmaceutically or veterinarily acceptable salts thereof and pharmaceutical compositions containing the same.
公开号:SU1299512A3
申请号:SU833578901
申请日:1983-04-07
公开日:1987-03-23
发明作者:Алпеджиани Марко；Бедески Анжело；Фолье Маурицио；Франчески Джованни；Перроне Этторе
申请人:Фармиталия Карло Эрба С.П.А. (Фирма)；
IPC主号:

专利说明:

or it is in the form of a reactive mixed acetal (II). The specified compound II reacts with AH, where A is indicated above, or its salt with an alkali metal, in an inert organic solvent medium, for example,,, (if necessary, in the presence of a base) at a temperature of (-70) ° C to room temperature followed by separation of the target product. If you need to get 1, where, then remove the protective group. Similarly, when it is necessary to have. Various substituents in Pv. When
use II, where OH is esterified, it is advisable to use methanesulfonic, p-toluenesulfonic, trifluoromethanesulfonic or p-bromobenzenesulfonic acid for sterification, and when OH is in the form of acetal, it is better to use neopentyl alcohol and dimethylformamide for its formation. Antibacterial potency 1 is higher than that of the known 7- | 3-cyanostillene (cis) thioacetamido-3-f (tetrazolo (1,5-b) pyridazin-8-amino-6-yl) thiomethyl-3-cephem- 4-carboxylic acid. 2 z. “. f-ly, 2 tab.
one
The invention relates to methods for producing new antibiotics, namely, substituted derivatives of 3-carboxylic acid penem or their esters, or their salts with alkali metals, which can be used as medicinal substances in medicine and veterinary medicine.
The aim of the invention is to obtain new penicillin antibiotics with increased antibacterial activity to the microbes of microorganisms that are insensitive to known antibiotics ..
The abbreviations pNB, THF, EtOAc, TBDM and TVDR5 mean, respectively, p-nitrobenzyl, tetrahydrofuran, ethyl apetat, t-butyldimethylsilyl and t-butyldiphenylsilyl.
Example 1. (5 R, 6S) tert-Butyldiphenyl-cycloyl ester (R) -OK- sistil1-2-methanesulfonyloxymethyl-3-carboxylic acid:
HE
Xh s
 Y (
he tn s

he
COOTBDPS
COOTBDPS
Triztilamine (45 µl, 0.32 mmol) and methanesulfonyl chloride (25 µl, 0.32 mmol) are sequentially added to a stirred solution of diphenyl-tert-butylsilyl ether (5R 6S) -6-l- (R) -oxyethyl -2-hydroxymethyl-3-carboxylic acid (150 mg, 0.31 mmol) in cold (-300 ° C) anhydrous dichloromethane (5 ml). The progress of the reaction is monitored by thin layer chromatography.
Then the reaction mixture is washed with an aqueous solution of NaHCOj and water, the organic phase is separated, dried over anhydrous NajSO4, and vashary. vacuum under the temperature below 50 ° С. Thus, the title product is obtained in the form of an oil (150 mg, 86%).
UV spectg (CHCI.) I
MdKC
329 nm.
f 5pii
NMR CCDC1) 5 ppm: 1.10 (9H, s); 1.34 (3N, d, 5 Hz); 3.10 (3H, s); 3.8) (IH, dd, 5-6.0 Hz); 4.21 (IH, M); 5.17 (2H, ABg, Hz, internal line separation 16 Hz); 5.66 (1H, d, 5 Hz); 7.21-7.85 (10K, m).
Example 2, tert-Butyldiphenylsilylmum sfir (5R, 6S) (R) -OK -seethyl -2g (1-methyl-1,2,3,4-tetrazol-5-yl) -thiomethyl1-penem-3 -carboxylic acid:
he
Ab
nJ-n-ch
ABOUT
HE N
 COOTBDPS
N-1

ABOUT
v-s4JV
And, sc.
CX) OTBDPS
to a solution of tert-butyldiphenylsilyl ester (5R, 6S) -6-t 1 (K) -ox.-ethyl--2-methanesulfonyloxymethyl-3-carboxylic acid (150 mg, 0.27 mmol) in ethyl acetate (- 2 ml) is added with stirring at -30 ° C a solution of 1-methi-5-mercapto-1,2,3,4-tetrazole sodium salt (41.5. G, 0.3 mmol) in anhydrous tetrahydrofuran (5 ml ).
The resulting mixture was compounded at -30 ° C for 6 hours and then evaporated under vacuum. The residue is taken up in ethyl acetate (5 ml) and washed thoroughly with aqueous NaHCO, and with water. The organic layer was dried over anhydrous Na SO and embedded in a vacuum, giving the title product as an oil (97 mg, 62%).
UV spectrum (CHC1) i Maca 337 named.
NMR (CDClp 8, ppm: l, 13 (9H, s) 1.34 (3N, d, 0 Hz); 3.82 (1H, dd, 0-6.0 Hz); 3.85 (3H, s); 4.19 (1H, m); 4.6 (2K, ABg, G internal line separation 17 Hz); 5.61 (1H, a, 5 Hz); 7.24-7, 83 (YUN, m).
Example 3. Sodium salt of (5R, 6S) (K) -oxyethyl -2 - {(1-me-, thyl-1,2,3,4-tetrazol-5-yl) -thiomethyl-penem-3- carboxylic acid:
N, 4-1I
II
S - ". NX-N Shz
COOT BOPS
Nt and
COONa Sig
Solution of tert-butyldiphenylsilyl ether (5R, 6S) (R) -oxyethyl to
15
20
25
995124
-2- (I-methyl-1,2,3,4-tetrazol-5-yl) - -thiomethyl-3-carboxylic acid foam (95 mg, 0.14 mmol) in tetrahydrofuran (2 ml), BUT ( 2 ml) and acetic acid (1 ml) are stirred at room temperature for 2 hours. The solution is then vacuumed under vacuum at a temperature below 10 ° C. The oily residue is taken up in 2% aqueous NaHCO (1 ml). The aqueous phase is washed with ethyl acetate and the organic phases are decanted. The aqueous phase is then passed through a reversed phase column. The title compound is obtained as a solid by means of water and obtained as an amorphous solid (34 mg, 67%).
UV spectrum (H 0) v 315 them.
NMR (DjO), h / mg: 1.28 (3N, d, 3 Hz); 3.87 (1H, dd,, 4, and 6.3 Hz); 4.10 (3N, s); 4.19 (1H, m); 4.40 (2H, ABg,, 0 Hz division of internal lines. Hz); 5.59 (1H, d, 4 Hz).
Example 4. The sodium salt of (5R, 6S) (K) -oxyethyl -2- (1-methyl-1,2,3,4-tetrazol-5-yl) -thiomethyl-penem-3-carboxylic acid:
he
1 s
x
0 COONa
young
HE N
about
N-14 S-Hij,;
COONa snake
five
0
five
Method A.
A suspension of the sodium salt of (5R, 6S) - -6- (R) -oxyethyl -2-oxymethylpenem-3-carboxylic acid (100 mg, 0.37 mmol) in anhydrous tetrahydrofuran (20 ml) is treated with tertbutyl diphenylsilyl chloride (96 ml, 0.37 mmol). The heterogeneous mixture is stirred for 2 hours at room temperature. The suspension is filtered and the filtrate is cooled at. Then, to this solution, N (C, jK5) j (52 µl, 0.37 mmol) and methanesulfonyl chloride (29 µl, 0.37 mmol) are added dropwise with stirring. After 30 minutes, the mixture is distributed between ethyl acetate and an aqueous solution of KAEOz.
The organic phase is thoroughly rinsed with water, dried over anhydrous NavSO, filtered and cooled again at .. The solution of sodium methyl-5-mercapto-1,2,3, 4-tetrazole (55.2 mg, 0.4 mmol) in tetrahydrofuran (10 ml) was added to this solution. After 6 hours at -30 ° C, the mixture is vacuum-dried and the residue is taken up in ethyl acetate and rinsed with water.
The dried organic phase is evaporated under vacuum and the oily residue is dissolved in tetrahydrofuran (2 ml). Acetic acid (1 ml) and water (2 ml) are added, and the solution is stirred at room temperature for 2 hours, and then it is evaporated under vacuum. The oily residue is dissolved in 2% aqueous NaHCO, washed with ethyl acetate and purified on a reverse phase column to give the title compound, which is identical to the compound described in Example 3.
Method B.
A suspension of sodium salt of (5R, 6S) - (K) -oxyethyl -2-hydroxymethylpenem-3-carboxylic acid (100 mg, 0.37 mmol) is treated with trimethylsilyl chloride (150 μl, 0.4 mmol) in anhydrous tetrahydrofuran. ). The heterogeneous mixture is stirred for 2 hours at room temperature. Then the suspension is filtered, and the filtrate is cooled to -30 ° C. Then, N (C-Hg), (52 µl, 0.37 mmol) and methanesulfonyl chloride (29 µl, 0.37 mmol) are added dropwise to the solution with stirring, and then after half an hour, a solution of 1-methyl sodium salt -5- -mercapto-1,2,3,4-tetrazole (55.2 mg, 0.4 mmol) in tetrahydrofuran.
The resulting mixture was stirred at for 6 hours, after which it was evaporated under vacuum to dryness. The residue is dissolved in water containing NaHCO and the solution is passed through a reversed phase column to obtain the title product, which is identical to the product obtained by method A,
The following compounds are prepared analogously:
potassium (5R, 6S) -6- (K) -oxyethyl-2- (1H-1,3,4-triazol-2-yl) -thiomethyl-penem-3-carboxylate. U (N.P) D j ,; 245 and 306 microns; NMR (D 0) &amp; : 1.27 (ЗН, d, 45 Hz); 3.80 (IH, dd.
4 and 5.0 Hz); 4.18 (IH, i); 4.37 (2H, ABg, Hz); 5.54 (IH, d, J 1.4 Hz) and 8.34 ppm (1H, S);.
potassium (5R, 6S) -6- (G) -oxyethyl -2- (1-methylimidazol-2-yl) -methoxy-penem-3-carboxylate. UV (P 0) D "(315 μm; NMR () o: 1.2.7 (3N, d, 4); 3.78 (3N, 8); 3.83 (IH, dd, 4 and 6 Hz; 4.07 and 4.31 (2H, each d, Hz); 4.25 (1H), (5.56-1H, d, 4 Hz); 7.05 and 7.27 h. ppm (2H, each d, 3 Hz);
potassium (5R, b8) -6- (III) -oxyethyl--2- (1H-1,2,3,4-tetrazol-5-yl) -thiomethylpenem-3-carboxylate, UV () maize 261 and 314 nm; tP (D, 0) S D 1.28 (3H, d); 3.82 (1H, dd, 5H6.0 Hz); 4.25 (1H, t); 4.42 (2H, ABg, J 14.4 Hz) and 5.53 ppm (1H, d. J
1.5 Hz);
potassium (5R, 6P,) - 6-Il (lR) -oxy-ethyl--2- (4-ethyl-1,2,4-triazol-3-yl) -thiomethylpenem-3-carboxylate. UV () ms, ks260 and 316 nm; IR (KVGU ax 3400,
1700, 1600, 1570 NMR () 1.30 (3N, d, 6 Hz); 1.42 (3N, t, J 5.6 Hz); 3.77 (W, dd ,, 6 and 5.6 Hz) 4.17 (2H, q, 6 Hz); 4.20 and 4.43 (2H, each d, Hz); 4.25 (1H, t); 5.52 (1H, d, 6 Hz) and 8.55 ppm (1H, s);
potassium (5R, 6S) -6-f (lR) -ooxyethylJ- -2- (2-methoxypyrazin-6-yl) -thiomethylpenem-3-carboxylate. UV (HjO) 251 and 326 nm; IR (KBr), 3430, 3040, 1765, 1620, 1570, 1550, 1520, 1490, and 1255 LR (1.30 (ZN, d); 3.77 (1H, dd); 3.97 (ZN, s) ; 4.25 (1H, t); 4.60 (2H, ABg); 5.55 (1H, d) and 7.8-8.0 ppm (2H, t);
potassium (5R, 6S) -6-C (lR) -oxyethyl--2- (2-amino-1,3,4-thiadiazol-5-yl) -thiomethylpenem-3-carboxylate. UV () 320 nm; IR (KBr) J: 3420, 3300, 3180, 1765, 1620, 1560 NMR (D, 0) 8: 1.30 (ZN, d); 3.92 (W, dd); 4, 28 (1H, t); 4.42 (2H, s) and 5.64 ppm (1H, d).
Example 5: (5R, 6S) -6-t1 (R) -n-HnTpo-benzyloxycarbonyloxyethyl-1-2-methyl-sulfonyloxymethyl-3-carboxylic acid p-nitrobenzyl ester:
H
about
he
COOp-NB
OC02PNB
Jh s
-
0 CpOpNB
 A solution of (5R, 6S) (K) -n-nitrobenzyloxycarbonyloxyethyl -2-hydroxymethyl-2-peach-3-carboxylic acid p-nitrobenzyl ether (100 mg, 0.178 mmol) in anhydrous dichloromethane (5 ml) sequentially treated at -15 ° C with triethylamine (58 mg, 0.58 mmol) and methanesulfonyl chloride (60 mg, 0.58 mmol). After 10 minutes, the reaction mixture was washed with an aqueous solution of sodium bicarbonate, and then with water. Succinated (Na SO) organic phase is extruded under vacuum to obtain the title product as a pale yellow syrup.
UV spectrum (CHC1), 325 nm NMR (CDCl1) 5 ppm: 1.51 (3N, d, Hz); 3.09 (ЗН, s); 4.02 (IK, dd, and 7.5 Hz); 4.92 and 5.64 (2H, center ABg Hz); 5.16 (1H, m); 5.25 (2H: s); 5.27 and 5.51 (2K, ABg Hz centers); 5.71 (1H, d, Hz); 7.50 (2H, d, Hz); 7.60 (2H, d, Hz); 8.20 (4K, two overlapping from the doublet, Hz).
, 10 M S (FD) m / e 637 (M). С Н J О, „. Required M, 637.
25 JP 3 Oe 2
11 p IMER 6. p-Nitrobenzyl ester (5R, 6S) (K) -p-nitrobenzyl-oxycarbonyloxyethyl -2-I-methyl-1,
2,3,4-tetrazol-5-ylthiomethyl-penem-3-carboxylic acid:
OS02rT4V
Day with
l- 0 COOp NB
Nn
COOpNB CH
The sodium salt of 1-methyl-5-mercaptotetrazole (52 mg, 0.3 mmol) sodium dihydrate is added in one portion to a cold solution in tetrahydrofuran (20 ml) of the mesylate prepared in Example 5 (38 mg, 0.06%). mmol)
After keeping for one hour at 0 ° C, the reaction mixture.
Extract and residue is chromatographed on silica gel, eluting with a mixture of cyclohexane / ethyl acetate. Thus, the title product is obtained as a pale yellow syrup (29 mg, 75%).
UV spectrum (СНС1) Л „(,,: 266 and 330 nm.
NMR (CBC1) 5, ppm: 1.48 (3N, d, Hz); 3.84 (1H, dd, and 5, .5 Hz); 3.96 (3N, s); 4.69 (2H, ABg, H, internal line separation 18 Hz); 5.20 (1H, m); 5.24 (2H, s); 5.27 (2H, ABg, Hz, internal extension line 20 Hz); 5.61 (1H, d, Hz); 7.51 (2H, d, Hz); 7.82 (2H, d, Hz); 8.02 (4H, two overlapping Hz doublets).
10M S (FD) m / e 657 (M). , Necessary, 657.
11p and meper 7. p-Nitrobenzyl ester (5R, 6S) (K) -p-nitrobenzyloxycarbonyloxyethyl -2-p-tols1-sulpenyloxymethyl-3-penem-3-carboxylic acid:

HE
OCOOpl B
1n s
tlTJ
O COOp-NB OCOOpNB n
-Hi
f-N- 0
os- {g cHb
0 COOpNB
five
0
five
To a stirred solution of p-nitrobenzyl ester (5R, 6S) (R) -p-nitrobenzyloxycarbonyloxyethyl--2-hydroxymethyl-3-carboxylic acid (56 mg, 100 µmol) in dichloromethane (2 ml) is added sequentially C triethylamine (17 μl, 120 μmol) and p-toluenesulfonyl chloride (21 mg, lib μmol). The resulting solution was stirred at 0 ° C for 15 minutes. An additional amount of triethylamine (10 µl) and p-toluenesulfonyl chloride (13 mg) was added, and the mixture was stirred for 20 minutes at 5 ° C. . After that, the organic solution is washed with a 4% aqueous solution of sodium bicarbonate and then with brine. The organic phase is dried over and concentrated under vacuum.
Chromatography of the residue on silica gel (eluted with hexane / ethyladetat) gives a light yellow oil (42 mg, 79%).
UV spectrum (CHC1.J) jl 267, 327 nm
IR spectrum (film) 111: 1795, 1750, 1710 cm-.
NMR (CDCl 3) ppm: 1.50 (3N, d,
, 0 Hz); 2.47 (3N, s); 3.82 (1H, dd, d, - 6.0 Hz); 5.00-5.55 (4H, 2ABg); 5.19 (1H, m); 5.31 (2H, s); 5.63 (1H, d, Hz); 7.27-7.82 (8H, m); 8.22 (4H, d, Hz),
PRI me R 8. p-Nitrobenzyl ester (5R, 6S) (K) -p-nitrobenzyl-hydroxycarbonyloxy1. -2- (1-methyl--1,2,3,4-tetrazol-5-yl) -thiomethyl-pene-3-carboxylic acid:
OCOOpNB
COOPTSlB
OCOOpNB
 COOp-NB CH-j
-N-n
sA &
A solution of (5R, 6S) (K) -p-nitrobenzyloxy-. -Carbonyloxyethyl -2-p-tolylsulfonyl-3-carboxylic acid p-nitrobenzyl ester (42 mg, 0.059 mmol) in tetrahydrofuran is treated with sodium salt dihydrate 1-meth-1-5-mercapto-1,2,3,4-tetrazole (52 mg, 0.3 mmol). The mixture is stirred for 3 hours at room temperature, the solvent is concentrated under vacuum and the residue is partitioned between ethyl acetate and aqueous NaHCO.
The organic phase is dried (Na ,, RO) and evaporated to give a crude product, which is purified on a silica gel column (ethyl acetate (Cg F,), thereby obtaining 26 mg (68%) of the title product, which is identical in all respects to the substance described in example 6.
PRI me R 9. p-Nitrobenzyl ether (5R, 6S) -6-Cl (K) -p-nitrobenzyl-hydroxycarbonyloxyethyl -2- (1-metsh-1, 2,3,4-tetrazole-5 -yl) -thiomethyl-p-3-carboxylic acid:
OCOOpNB
frV -
 COOpNB OCOOpNB-xj -XT
ITT-
L |.,
 COOpNB SNS
0
A solution of diethyl azodicarboxylate (21.6 μl, 0.137 mmol) and triphenyl phosphine (36 mg, 0.137 mmol) in tetrahydrofuran (1.5 ml) was stirred for 30 minutes. A solution of p-nitrobenzyl ester of (5R, 6S, 8R) -6-l (ln-nitrobenzyl-; -Cicarbonyloxyethyl) -2-oxymethylphene-nem-3-carboxonic acid (76 ° C) is added dropwise to this mixture at 0 ° C. 5 mg, 0.137 mmol) and sodium salt of 1-methyl-5-mercapto-1,2,3,4-tetrazole (18.9 mg, 0.137 mmol) in tetrahydrofuran (1.0 ml).
The resulting solution was stirred at 0 ° C for 10 minutes, then concentrated under vacuum and purified by preparative thin layer chromatography to give the title compound as a white foam (61 mg, 68%)
UV spectrum (CHCI3) D 266, 330 nm.
 (CDClj) S ppm: 1.48 (3N, d, J Hz); 3.84 (IK, dd,, 0, and 5.5 Hz); 3.96 (3N, s); 4.69 (2H, ABg, Hz, internal line separation 18 Hz); 5.20 (1H, m); 5.24 (2H, s); 5.27 (2H, ABg, Hz, separation of internal lines, 20 Hz); 5.61 (1H, d,, 0 Hz); 7.51 (2H, d, -, 0 Hz); 7.82 (2H, d,, 0 Hz); 8.02 (4H, d,, 0 Hz).
Example 10. (5R, 6S) p-Nitrobenzyl ester (R) -n-HHTpo6eH3Rn-oxycarbonyloxymethyl -2- (1-methyl--1,2,3,4-tetrazol75-yl) -methimene-pemen-3-carboxylic acids:
OSOGRT VN S
 TOG
, (
OSOgr15V H S
OH COOpNB
N-1
.
COOp NB SNS
eleven
A solution of (5R, 6S) n-nitrobenzyl ester (K) -nitrobenyl-xycarbonyloxyethyl -2-hydroxymethyl-pe-3-carbronic acid (300 mg, 0.536 mmol) in acetonitrile (10 ml) is treated with anhydrous 1-methyl-5- mercapto-1,2,3,4-tetrazole and dimethylformamide di-neopentyl acetate (each taken 1.07 mmol). After stirring for 3 hours at room temperature, the solvent was removed under vacuum and the residue was chromatographed on silica gel to give. Named product with low yield.
IR (CH (P)) 1795 i 1755, 1710.
The product has the same NMR and UV spectra as the substance obtained according to example 9.
Example 11 Sodium salt of (5R, 6S) -6-Cl (E) -oxyl-2H (1-methyl-1, 2,3,4-tetrazol-5-yl) -thiomethyl-foam-3-carbon acids:
Nn
OSOGR IN
: Szd,
  SOORIB Shz
TSHS COONQ SNS
To a solution of (5R, 6S) -6-Cl (R) -n-nitrobenzenyloxycarbonyloxyethyl -2- (1-methyl--1,2,3,4-tetrazol-5-yl) p-nitrobenzyl ester n-3-carboxylic acid (100 mg, 0.15 mmol) in tetrahydrofuran (1.5 ml) is added with an intensive transfer of an aqueous solution of NH C1 (1 mol / l, 7.5 mp) and an iron powder (0, 25g)
After 20 minutes, an additional amount of an aqueous solution of ammonium chloride (1 mol / l, 5 ml) and iron powder (1.1 g) was added, and the transfer was continued for 45 minutes. The mixture is filtered and the filtrate is washed with diethyl ether (2 KZO ml). The organic layer is poured and the aqueous phase is evaporated to dryness under vacuum. The residue is purified on a reverse phase column, eluting with water, to give (5R, 6S) -6-Cl- (R) -oxyethyl -2-C (1-methyl-1,2,3,4-tet
212
Razol-5-yl) -thiomethyl1-penem-3-carboxylic acid (20 mg), which is converted by treatment with an equimolar amount of sodium bicarbonate, followed by vacuum drying, into the corresponding sodium salt identical to the sample prepared in Example 3. Example 12 , p-Nitrobenzyl ester of (5R, 6S) -6-tl (I) -oxyethyl -2- -methylsulfonyloxymethyl-3-carboxylic acid
HE
(
he
СООРТ В
) H


- jirOr
A solution of p-nitrobenzyl ester (5R, 6S) (R) -oxoxy {w -2-oxymethylpenem-3-carboxylic acid (100 mg, 0.27 mmol) in a mixture (4 ml) and tetrahydrofuran (1 ml) i treated by transferring with Et N (56 µl, 0.4 mmol) and methanesulfonyl chloride (23 µl, 0.3 mmol) until the reaction is complete (monitored by thin layer chromatography).
The solution is diluted with aqueous NaHCO and washed thoroughly with water.
The aqueous phase is drunk and the dried organic phase is evaporated under vacuum to give the title product as a yellow oil.
NMR (CDCl 3) S ppm: 1.45 (3N, d, 5 Hz); 3.11 (3N, s); 3.84 (1H, dd, 5, 6.1 Hz); 4.25 (1H, m); 5.33 (2H, ABq, Hz, separation of internal lines 10 Hz); 5.38 (2H, ABq, Hz, ra: separation of internal lines 24 Hz); 5.75 (1H, d, 5 Hz); 7.61 (2H, d, Hz); 8.02 (2H, d, Hz).
Example 13. p-Nitrobenzyl ester of (5R, 6S) (I) -oxyethyl -2- (1-methyl-1,2,3,4-tetrazol-5-yl) - -thiomethylpene-3-carboxylic acid :
0802СНз COOpNB
13
B1-n
HE
JLy s „..
- r
C)
COORMV 3
to a solution of (5R, 6S) (K) -oxyethyl -2- -methylsulfonyloxymethyl-3-carboxylic acid p-nitrobenzyl ester (70 mg, 0.154 mmol in ethyl acetate (2 ml) is added with stirring at -70 ° C sodium solution 1-methyl-5-mercapto--1,2,3,4-tetrazole salts (53.6 mg, 0.3 mmol) in tetrahydrofuran (5 ml
After 1 h, the temperature of the reaction mixture was raised to -20 ° C and stirred overnight at -20 ° C.
Then the solution is evaporated under vacuum. The resulting solid is dissolved in ethyl acetate and washed with an aqueous solution of NaHCO.
The organic phase is separated, dried over anhydrous Na SO, filtered and evaporated under vacuum to give a yellow oil, which is purified by chromatography on a column, eluting with ethyl acetate / cyclohexane.
Thus, the title compound is obtained as a colorless oil (40 mg, 30% complete yield, starting from a 2-hydroxymethyl intermediate).
UV spectrum (СНС1) Д: 255,
3 max 334 nm,
NMR (CDCl1) s ppm: 1.38 (3F, d, Hz); 3.77 (1H, dd,, 0, and 6.0 Hz) ;. 3.93 (3N, s); 4.27 (2H, ABq, Hz, internal line separation 16 Hz); 4.77 (2H, ABc |, Hz, division of internal, lines 16 Hz); 5.30 (2H, s); 5.33 (2H, ABq, Hz, internal line separation 9 Hz); 5.64 (1H, d,, 0 Hz); 7.56 (2H, d, Hz); 8.22 (2H, d, Hz).
Example 14. Sodium salt
(5R, b8) -6-G1 (K) -oxyethyl -2CH (1-methyl-1,2,3,4-tetrazol-5-yl) thiomethyl-3-carboxylic acid.
An aqueous solution (1 mol / L, 2 ml) and powdered iron (0.1 g) are added to a tetrahydrofuran solution of p-nitrobenzyl ether (5R, 6S) -6-tl (I) -oxyethyl -2- (1-me - Tyl-1,2,3,4-tetrazol-5-yl) -thiomethyl penem-3-carboxylic acid (40 mg, 0.083 mmol). The mixture is vigorously stirred for 30 minutes at com
five
W) .15
20
25
214
temperature is added, after which, if required (monitored by thin layer chromatography), a suppressive amount of reagents is added. When the starting material disappears, the mixture is filtered, the filtrate is washed with ethyl ether (ml) and concentrated to a small volume under a high vacuum and purified on a reverse phase column, eluting with water. A named product identical to the sample described in Example 3 was obtained by treatment with sodium carbonate and freeze-drying as a white amorphous solid (18 mg, 59%).
Example 15. (5R, 6S) tert-Butyldiphenylsilyl ether (R) -TpeT-butyldimethylsilyloxyethyl -2-hydroxymethyl-3-carboxylic acid:
OTBDMC

OTBDM5
Jc
HE COOTBDPS
The sodium salt of (5R, 6S) -6-t (R) - -tert-butyl-benzylmethylsilyloxyethyl -2-oxymethyl-ene-3-carboxylic acid (30 mg, 78.6 mmol) is suspended in anhydrous tetrahydrofuran (4 ml).
tert-Butyldiphenylsilyl chloride (20.1 µl, 78.6 mmol) was added at room temperature.
After stirring for 30 minutes, triethylamine (5.5 µm, 39.3 mmol) and additional tert-butyldiphenylsilyl chloride (10 µl, 39.3 mmol) are added. Within half an hour the precipitate is completely dissolved. The solution is concentrated and the residue is chromatographed on silica gel, eluting with cyclohexane / ethyl acetate, to give a colorless oil (30 mg, 64%)
UV spectrum (CPC1) x: 331 nm.
IR spectrum (): 1790, 1710 cm.
Ж1Р (СОС1e) 8, ppm: 0.07 and 0.08 (ЗН, twos); 0.88 (9H, s); 1.10 (9H, s); 1.24 (ЗН, d,, 0 Hz); 3.50 (1H, t) exchange with DgO; 3.77 (1H, dd,, 5, and 5.0 Hz); 4.24 (N, m); 4.42 (2H, d, singlet after the exchange with);
5.63 (IH, d, 5 Hz); 7.2-7.8 (UN, m).
Example 16. tert-Butyldiphenylsilyl, 1st ester (5K, 6S) (I) - -tert-butyldimethylsilyloxyethyl -2- - (1-methyl-1,2,3,4-tetrazol-5-yl) - -thiomethylpene -3-carboxylic acid:
QTBDMS
V
n / -N-kpr
Otbdhs
F, C
 ,
COOTBDPS TSi-N
Shz COOTBDPS
To an ice-cooled solution of tert-butyldiphenylsilyl ether (5R, 6R) -6-Cl (K) -t-butyl dimesh1-silnloxyethyl 2-hydroxymethyl-3-carboxylic acid (47 mg, 78.6 mmol in anhydrous tetrahydrofuran (A, 5 ml ) triethylamine (11 µl, 78.6 mmol) and methanesulfonyl chloride (6.1 µl, 78.6 mmol) are added. The solution is stirred for 10 minutes at 0 ° C and then the sodium hydrate 1- is added in one portion methyl-5-mercapto-.1,2,3,4-tetrazole (27.4 mg, 157.2 mmol). The resulting mixture was stirred at 0 ° C for 75 minutes.
The residue obtained after evaporation of the solvent was purified by column chromatography (silica gel column, elution with a cyclohexane / / ethyl acetate), to give the title compound as a white foam (34 mg, 60%).
UV spectrum (SNG) L "lks 338 them.
This product is directly used for the next step (double desylation).
Example 17. Sodium salt of (5R, 6S) -6-Il (K) -oxyethyl -2- (1-methyl-1,2,3,4-tetrazol-5-yl) -thiomethyl-penem-3-carboxylic acid :
Tl
,
 CHf COOTBDpS
COONa snake
Nn
s-do
A solution of (5R, 6S) tert-butyldiphenylsilyl ether (K) -t -butyl-dinylsilyloxyethyl -2- (1-methyl-1,2,3,4-tetrazol-5-yl) -thiomethyl pene-3-carbon Acids (34 mg, 0.049 mmol) in tetrahydrofuran (15 ml) are treated with 50% aqueous acetic acid (10 ml). The mixture is stirred for 20 hours at room temperature and then evaporated to dryness under vacuum. The residue was dissolved in iced distilled water (I ml), and sodium bicarbonate was added with stirring to bring the pH to 7.5. The solution is washed with ethyl acetate and then passed through a reverse phase column to give the title product as an amorphous solid (4 mg, .22%).
Example 18. (5R, 6S) (K) -tert-butyl-dimethylsiloxyethyl -2- (1-methyl-1,2, 3,4-tetrazol-5-yl) thiomethyl-penem-3-carboxylic acid acetoxymethyl ester:.
OTBDMS
S-jt
O n-kcf
he
SOOCH20SSNz
about
TYa-N
,
OTBDMS
-C- v
IIjT
 0 СООСНг СНт
OOSN
Diethyl azodicarboxylate (216 µl, 0.137 mmol) was added to a stirred solution of triphenylphosphine (36 mg, 0.137 mmol) in tetrahydrofuran (0.5 ml) at 0 ° C.
The mixture was stirred at 0 ° C for 30 minutes, then it was added to a solution of (5R, 6S) acetoxymethyl ester (K) -tert-butyldimethylsilyloxyethyl -2-hydroxymethyl-2- -perene-3-carboxylic acid ( 59 mg, 0.137 mmol) and sodium salt of 1-methyl 5-mercapto-1, 2,3,4-tetrazole (18.9 mg, 0.137 mmol) in tetrahydrofuran (2 ml) at 0 ° C. The mixture is stirred at 0 ° C for 15 min.
The resulting solution was concentrated under reduced pressure, and then purified by chromatography on a column (silica gel, elution, with a mixture of hexane / ethyl acetate), to give the title compound as a white foam (38 mg, 58%). UV spectrum (СНС1), „(, с: 335 nm.
IR spectrum (CHCl j) n: 1785, 1760, 1720 cm-.
NMR (CDCl1) 5 ppm: 0.05 (6H, 9); 0.87 (9H, s); 1.19 (3N, d, J 6.0 Hz); 2.18 (3N, s); 3.68 (1H, dd,, 0, and 4.0 Hz); 3.92 (3N, s); A, 21 (W, m); 4.72 (2H, ABg, J, 5 Hz, internal line separation 15 Hz); 5.54 (1H, d,, 0 Hz 5.92. (2H, ABg,, 0 Hz, separation of internal lines 1 Hz).
Example 19. (5R, 6S) -6-ri (K) -p-nitrobenzyloxycarbonyloxyethyl -2-acetoxymethyl-3-carboxylic acid p-nitrobenzyl ester
OS02R
-H-g
COOP
system
xNp- Y OCOCH
P-ISJ G.P.
C000NB
A solution of (5R, 6S) -6-tl (K) -p-nitrobenzyloxycarbonyloxyethyl -2-hydroxymethylpenem-3-carboxylic acid p-nitrobenzulate ester (350 mg, 0.58 mmol) in anhydrous CHgCl j (5 ml) treated with pyridine (140 mg) and acetic anhydride (80 mg), and then the mixture is stirred at room temperature for six hours. The mixture was washed with aqueous NaHCOe (3-5 ml) and water (1-5 ml). Dried On SO. the organic phase is evaporated and the oily residue is purified by chromatography on silica gel (eluent: cyclohexane-ethyl 1-acetate) to obtain the title product as a syrup (200 mg).
UV spectrum (Eton 95%) I and 321 nm.
(Lacs
265
five
Zh-spectrum (CHC1): 1795, 1750, 1715, 1610 and 1585 cm-
LR (CDCl1), ppm: 1.50 (3N, d, Hz); 2.11 (3N, s); 4.01 (1H, dd, 8 and 7.5 Hz); 5.11 and 5.50 (2H, centers ABq, Hz); 5.15 (1H, m); 5.24 and 3.38 (2H, centers ABq, Hz); 5.28 (2H, s); 5.70 (1H, d, 8 Hz); 7.35 (2H, d, Hz); 7.64 (2H, d, Hz); 8.22 (4H, d two overlapping doublets of J 8 Hz).
EXAMPLE 20 p-Nitrobenzyl ester of (5R, 6S) -6- (R) -n-nitro-benzyl-hydroxycarbonyloxyethyl -2-t 1- (2-1-aminocarbonylethyl) -1,2,3 , 4-tetrazol-5-yl-thiomethylpenem-3-carboxylic acid:
 ; №c
OCOzpNB H
OSChCH COORKV
AO
COOpNB SNGHGSOYN
five
0
five
0
five
To a solution of (5R, 6S) p-nitrobenzyl ester (K) -p-nitrobenzyloxycarbonyloxyethyl -2-mesyloxy-methyl-2-penem-3-carboxylic acid (38 mg, 0.06 mmol) in anhydrous tetrahydrofuran (5 ml ) at the room temperature, triethyl ammonium salt of 1- (2-aminocarbonyl-ethyl) -5-mercaptoterazole (80 mg, 0.3 mmol) is added. After half an hour, the reaction mixture is evaporated under vacuum. The residue is chromatographed on a silica gel, eluting with a cyclohexane / / ethyl acetate mixture to give the title product as a syrup.
UV spectrum (СНС1) Х „a: 266 and 332 nm.
IR spectrum (SNL) 1) „„,: 3500, 3400, 1795, 1750, 1710-1695, 1605 cm.
Ж1Р (СОС1з) 8, ppm: 1.47 (ЗН, d, Hz); 2.7 (2H, t, Hz); 3.83 (1H, dd, and 5.5 Hz); 4.3-5.0. (4H, m); 5.2 (1H, m); 5.25 (2H, s); 5.3 (2H, center ABq); 5.62 (1H, d, Hz); 7.5 and 7.81 (each 2H, d, Hz); 8.0 (4H, two overlapping doublets, J-8 Hz).
MS (FD) m / e 714 (M) C AND., S,.
Required M, 714.
V
nineteen
PRI me R 21. Sodium salt of (5R, b8) (K) -oxyethyl -2- - - (2-aminocapbonylethyl) -1,2,3,4-tetra-5-ylJ-thiomet, ylpenene -3-carboxylic acid:
1I-K
OCO-ipNB
I N with; d, X,
- Ni - s4 i
RS V
COOpNB CH2CH ONH2
HE
Cr
Nn
СООЫа Ш2СН2СОКН2
A solution of n-nitrobenzyl ether (5R, 6S) (K) -p-nitrobenzyloxy-
carbonyloxyethir13-2- 1- (2-aminocarbonylethyl) -1,2,3,4-tetrazol-5-yl - -thiomethylpenem-3-carboxylic acid (100 mg, 0.14 mmol) in acetonitrile (5 ml) Treat with a solution of Na S O (73 mg, 0.42 mmol) and NaHCO in bottling water (4.2 ml).
The mixture was stirred at room temperature, controlling the reaction by thin layer chromatography. When the reaction was almost complete, the solvent was evaporated under vacuum, the aqueous solution was washed with ethyl acetate, and then passed through a reversed phase column to give the title product.
UV spectrum (KjO): D 315 nm.
IR (CCG) v: 3400, 1770 and 1695 and 1610 cm
M S (FD) m / e (free acid) 400 (M). For C & M, M 400 is required. T3 166 5 2
In a similar way, the sodium salt of (5R, 6S) -6-ll (K) -oxy- (2-aminocarb6nylmetsh1) -1.1,3,4-tetrazol-5-yl} -thiomethyl pemen-3-carboxylic acid is obtained. .
Example 22. Sodium salt of (5R, 6S) (R) -oxoxy-2- (5-methyl-1,2,3,4-diadiazol-2-yl) tyometnyl penem-3-carboxylic acid:
HE
Ln S t
he
cooNa
1299512
20 .

he
o - sooma
Tert-butyldiphenylsilyl chloride (0.1 ml) was added to a suspension of sodium salt (5R, 6S) (R) -OKCH-ethyl -2-hydroxymethyl-3-carboxylic acid (100 mg) in anhydrous tetrahydrofuran. After stirring for 2 hours at room temperature, the insoluble material is filtered off and the filtrate, cooled to, is treated with methanesulfonyl chloride (0.03 ml), and then after 30 minutes with a solution of sodium salt 5-methyl, -2-mercapto-1 - 3,4-thiadiazole (60 mg) in tetrahydrofuran.
The mixture is kept overnight at -30 ° C, and then it is evaporated under vacuum, partitioned between ethyl acetate and water, and the organic phase is evaporated again to give a crude tertbutyldiphenylsilyl ester of the title product. Desilylation with aqueous acetic acid and purification as described in Example 4, gives the final compound as an amorphous solid.
UV spectrum (BUT) I poppy ,. : 314 nm.
NMR (D, jO) 8 ppm: 1.37 (3N, d); 2.77 (LC, s); 3.87 (1H, dd); 4.30 (1H, m); 4.62 (2H, ABq); 5.62 (IH, d).
EXAMPLE 23 (5R, 6S) - ((R) -oxyethyl -2 -ll- (2-dianoethyl) p -Nybrobenzshtovy ether (5R, 6S) -. (1), 2,3,4-tetrazol-5-yl -thiomethyl-3-carboxylic acid:
HE
L s
t - g
OLDR
COOpNB
Yun

Y-Ty
COOpNB CHzCH CN
(5R, 6S) - (R) -OKCH3TmT -2-hydroxymethylpenem-3-carboxylic acid n-nitrobenzyl ester (37 mg, 0.1 mmol) is added to a stirred solution of N, N-diisopropylethylamine (35 µl, 0, 2 mmol) in anhydrous dichloromethane (1 ml). Then add 2
trifluoromethanesulfonic anhydride (25 μl. O ,, 15 mmol) were added, the mixture was stirred for 20 minutes at room temperature, cooled in an ice bath and treated with an additional amount of diisopropyl ethylamine (26 μl, 0.15 mmol), and immediately after this 5-mercapto-11- (2- -cyanoethyl) -, 2,3,4-tetrazole (23 m 0.15 mmol). After 2 hours at 0 ° C, ethyl acetate is added (10 ml) and the resulting solution is washed successively with water, with a 5% aqueous solution of citric acid and with a 5% aqueous solution of sodium bicarbonate. The organic layer is dried over Na PO, concentrated under vacuum and the residue is fractionated by chromatography on silica gel (ethyl acetate / cyclohexane mixture) to obtain the title compound (35 mg, 68%) as a foam. IR spectrum (SNSC), 2240, 1795, 1755, 1710.
NMR (COClS) b, ppm: 1.37 (ERA, d, Hz); 3.20 (2H, t, Hz); 3.77 (1H, dd, and 6 Hz); 4.30 (N m); 4.62 (2H, t, Hz); 4.8 (2H, ABq, Hz); 5.30 (4H, s + ABg); 5.65 (1H, d, Hz); 7.6 and 8.23 (each 2H, d, Hz).
PR and N e p 24. Sodium salt of (5R, 6S) (R) -ooxyethyl -2- l- (2- -cyanoethyl -1,2,3,4-tetrazol-5-yl} - -thiomethyl-3 carboxylic acid
n S n- -
COORSH CH CH-jiCN
-N-n
HE

.SOOMa
(5R, 6S) -6- (R) -oxy-ethyl-2- - (2-cyano-methyl) -1,2,3,4-tetrazol-5-yl-thiomethine-3-p-p-nitrobenzyl ester carboxylic acid (35 m 0.068 mmol) dissolved in tetrahydrofuran (15 ml), treated with aqueous Nb C1 (1 mol / l, 1.5 ml) and iron blemish (0.1 g) with vigorous stirring. After 30 minutes, the filtrate is evaporated under vacuum and passed through a reverse phase column, eluting with water, to give
9951
h g Yu yt5 - 20
25, 30
2 22 thus 12 mg (45%) of the free acid corresponding to the named product. M S (FD) m / e 382 (M). For, H requires M, 382.
By treating the free acid with an equimolar amount of sodium bicarbonate followed by freeze-drying, the corresponding sodium salt is isolated.
UV spectrum (N.P.) 315 nm. IR (KBr): 3430, 2250, 1765 and 1615.
NMR (DjO) S ppm: 1.26 (3N, d., 4 Hz); 3.23 (2H, t); 3.84 (1I, dd, 4, and 6.0 Hz); 4.20 (1H, t); 4.54 (2H, ABq, 2 Hz); 4.8 (M, t); 5.58 (1H, d, 4 Hz).
In a similar way, the sodium salt of (5R, 6S) (R) -OK is obtained from the set-2-t salt. 1- (2-cyanomethyl) -1,2,3,4-β-tetrazol-5-yl3-thiomethylpenem-3-carboxylic acid.
PRI and MERP 25. Disodium salt of (5R, 6S) (K) -oxyethyl1-2- (5-carboxymethylthio-1,3,4-thiadiazol-2-yl) - -thiomethylpene-3-carboxylic acid :
he
about
Ajis ,,
COOTBDPS

 n cN - N
/№s.s4sA
 I-I-JLS-CH COONa
0COONa
A solution of 2-mercapto-5-carboxymethylthio-1,3,4-thiadiazole (41.6 mg, 0.2 mmol) and triethylamine (56 µl, 0.4 mmol) in anhydrous tetrahydrofuran is added at -30 ° C in an argon atmosphere to a solution of tert-butyldiphenylsilyl ether (5R, 6S) -6- (K) -oxyethyl32-methanesulfonyl-methyl-ethylbenzene-3-kg of carboxylic acid (85 g, 0.15 mmol) in the same solvent. After stirring for 5 hours at, the reaction mixture is concentrated under vacuum, dissolved in ethyl acetate and extracted with water.
The organic layer is poured, the aqueous layer is acidified with acetic acid and extracted twice with fresh ethyl acetate. This extract is dried (Na YAO) is concentrated, dissolved in Tetra23
hydrofuran (3 ml) and stirred for 2 hours with 35% aqueous acetic acid. The reaction mixture was concentrated under high vacuum, treated with saturated NaHCO solution to pH 7.5 and fractionated on a reverse phase column, eluting with water, thus obtaining the title compound 22 mg, 32%).
UV spectrum () I: 314 nm. NMR (D, jO) S ppm: 1.25 (3N, d); 3.85 (1H, dd,, 5, and 6 Hz); 3.97 (2H, S); 4.2 (1H, m); 4.55 (2H, s); 5.57 (IH, d, 5 Hz).
In a similar way, the disodium salt of (5R, 6S) -6-Ll (R) - -oxyethyl -2- (5-carboxymech1-1,3,4-β-thiadiazol-2-sh1) -thiomethylpene-3-β-carboxylic acid is obtained.
; EXAMPLE 26. Sodium eol (5R, 6S) (K) -oxyetch1; -2- (1H- -1,2, 3-triazol-5-yl) -thiomethylpenem-3-carboxylic acid:
.he
HE,, ,
I n h NT-N
-: Mr.
0 SOSHA A
Sodium salt of (5R, 6S) (R) - -oxyethyl -2-hydroxymethyl-3-carboxylic acid (80 mg, 0.3 mmol) is treated successively with tert-butyldiphenylsilyl chloride (78 μl), triethylamine (42 μl), methanesulfo - nilchloride (24 μl) and, finally, the sodium salt of 1H-5-mercapto-1,2,3-triazole (43 mg, 0.35 mmol) according to the experimental procedure described in example 4.
The ester of the title product thus obtained is directly split with a mixture of acetic acid-water to obtain, after treatment with an aqueous solution of NaHCO, and purification on a column (Li Chroprep RP-18) the desired sodium salt (49 mg 47%).
UV spectrum (H-HO),
: 314 nm.
IR spectrum (KBr) V,: 1610 CM V
MS (FD) m / e (free 328 (M). For C N N OS M, 328.

12995122Д
PRI me R 27. Acetoxymethyl
(5R, 6S) ester (I) -oxyeth-2-t1- (2-dimethylamino-ethyl) -1,2,3,4-tetrazol-5-yl-thiomethyl-penem-3-carboxylic acid:
) H
ProprO -
g, K SOOCHN.0SOSN-3
 -one
,
 CH2CHNg (CH3) 2
Soos
0
-B

Triethylamine (42 µg, 0.3 mmol) and methanesulfonyl chloride (17 µl, 0.22 mmol) are sequentially added to a cold solution (O C) of acetoxymethyl ester (5R, 6S) -6- (R) -oxy-ethyl -2 -Oximethylphenemic-3-carboxylic acid (60 mg, 0.2 mmol) in a mixture of dichloromethane (4 ml) and tetrahydrofuran (1 ml). When the starting material disappears (by thin layer chromatography), the solution is washed with an aqueous solution of NaHCO, then with water, dried, and vanish. The residue is dissolved in ethyl acetate (5 ml), cooled to -30 ° C and treated with a solution of the 5-mercapto-1- (2-dimethylaminoethyl) -1,2,3,4-tetrazole hydrochloride salt (63 mg, 0.3 mmol) and triethylamine (84 μl, 0.6 mmol) in tetrahydrofuran (1 ml). The mixture is stirred overnight at −20 ° C., warmed to room temperature, washed with water, dried (Na RO) and entrenched to give a residue, which is purified by reverse phase chromatography (acetonitrile / water mixture as eluant). In this way, the title product is obtained in the form of a crumbly foam (58 mg, 61%).
UV spectrum (EtOF) XMaKc5 335 nm.
IR spectrum (nudzhol) „(.: 1785, 1760, 1720 cm.
lP- (EtOH-dg) 8 ppm: 1.45 (3N, d, 5 Hz); 2.9 (6H, s); 3.65 (3N, t + dd); 4.10 (IH, m); 4.7 (5H, t, + ABq); 5.55 (IH, d, 5 Hz); 5.9 (2H, ABq,, 0 Hz).
PRI me R 28. Disodium salt (5R, 6S) -6-ll (R) -oxy-ethyl -2- (l-Cap25
boxymethyl-1,2,3,4-tetraeol-5-yl) thiomethylpenem-3-carboxylic acid:
F
Sosha
rjC -
 SCHOSCH CHICOONa
-N
BUT
Following the experimental procedure described in Example 4, the (5R, 6S) (K) -oxyethyl - -2-hydroxymethylpenem-3-carboxylic acid sodium salt (100 mg, 0.37 mmol) is successively subjected to esterification with t-butyldiphenylsilyl chloride is converted into a mesylate, contacted with 1-carboxymethyl-1,2,3,4-tetrazol-5-thiol (64 mg, 0.4 mmol) in the presence of diisopropylethylamine (0.14 ml, 0.8 mmol) and Finally, the silyl ester is hydrolyzed with a mixture of tetrahydrofuran-H 0-acetic acid. Treatment and purification on a reverse phase column gave the title compound (40 mg, 23%)
315 nm
, t / 1-1ll 1.28 (3N, d, 6.3 Hz); 3.85 (1H, dd,, 4, and 6.3-Hz); 4.2 (1H, m); 4.4 (2H, ABq) 5.3 (2H, s); 5.60 (1H, d, 4 Hz).
Example 29. Disodium salt of (5R, 6S) (K) -oxy ethyl 1-2 - (1- (2-carboxyethyl) -1,2,3,4-tetrazol-5-yl-thiomethylpenem-3-carboxylic acid:
UV spectrum (H, 0) L, QKc: NMR (1), 0) 5 ppm:
about
.
-HE
 and-
 COONa
Nn
ZD
1G-N
COONa CH-iCH COONa
If in the way, the following example
described in pre-use of 5- -mercapto-1- (2-carboxyethyl) -1,2,3,4-tetrazol instead of 5-mercapto-1-carboxymethyl-1, 2,3, 4-tetrazole, then the title compound is obtained.
129951226
UV spectrum (N. O) D g NMR (DO) 5, ppm:
: 315 nm. 1.3 (3N, d); 3.9 (1H, dd); 4.2 (1H, m); 5.58 (1H, d, J
2.85 (2H, t) m); 4.4 (4H, 1.4 Hz).
MS (FD) m / e (free acid) 401 (M). For C N N-0 I require
15 5 2 i
m 401.
P-p and meraz O. Disodium salt of (5R, 6S) -6-.l (R) -oxyethyl -2- (l-methyl-methyl-1,2,3,4-tetrazol-5-yl ) -thio-methylpenem-3-carboxylic acid:
HE
o TM N: ooNa
he
--b
Nn
EH
COUCH CH SOjNa
five
0
five
0
five
0
five
The sodium salt of (5R, 6S) (R) - -oxyethyl1-2-hydroxymethyl-3-carboxylic acid (80 mg, 0.3 mmol) in anhydrous tetrahydrofuran is mixed with tert-butyldiphenylsilyl chloride (78 μl) for 2 hours. Insoluble substances are filtered off, cooled to, treated with N (C Hg), (42 µl) and methan- jes chloride (25 µl), and the mixture is stirred for another 10 min at -20 ° C, after which it is added portionwise two 1-sulfometyl-1,2,3,4-tetrazol-5-thiol sodium salt (72 mg, 0.3 mmol). The mixture is stirred for 6 h at -2P With, then evaporated under vacuum and triturated with ether. The collected solid solution (dissolved in a mixture of tetrahydrofuran, water and acetic acid (2: 2: 1), stirred for 2 hours at room temperature, evaporated under vacuum, and taken up in 2% aqueous NaHCO solution, washed with ethyl acetate and then passed through a reverse phase column to give the title product.
UV spectrum (F ,, 0) A j: 315 nm.
IR spectrum (K-Br),: 3400, 1770 and 1610 cm
In a similar way, the disodium salt of (5R, 6S) (R) -α-oxymethyl -2- (1-sulfoethyl-1, 2,3,4-β-tetrazol-5-yl) -thiomethylpene-3-carboxylic acid is obtained.
Launching the final treatment with an aqueous solution of NaHCOj, the corresponding free acids are obtained: (5R, 6S) -6-Cl (K) -o Seatnl -2- (1-sulfomethyl--1,2,3,4-tetrazol-3-yl) -thiomethyl-penem-3-carboxylic acid. MS {FD) m / e 423 (M). For C ,,, Sj, N 423 and (5R, 6R) (R) -OKCH-ethyp7-2- (1-sulfoethyl-1,2,3,4-tetrazol-5-yl) -thiomethylenem-3 - carboxylic acid.
PRI me R 31. Disodium salt of (5R, 6S) (R) -OKCH3Tmi -2-Ll- (2- sulfoaminoethyl) -, 2,3,4-tetrazol-5-yl-thiomethylpenem-3- carboxylic acid:
HE
Un s
-TTi
Sosh
COONa CH -CHx-NH-SOjNa
N-n II
W
Following the procedure described in Example 37, using the 5-mercapto-1- (2-sulfoamino-ethyl) -1,2,3,4-tetrazole disodium salt instead of the 5-mercapto-1-sulfomethyl-1,2,3 , 4-tetrazole, (5R, 6S) (R) -OKCH-ethyl -2-hydroxymethyl-3-carboxylic acid sodium salt is converted to the title product in a 20% yield.
UV spectrum () 134 nm.
Infrared spectrum (KVg)))
Max
3420, 1770,
.YY11ZHGCH.-
and 1610 cm
 MS (Fn) m / e (free acid) 452 (). For C P N 0, .I, requires M, 452 .. 7 3
Example 32. Disodium salt of (5R, 6S) -6-Cl (R) -oxyethyl -2- (4-methyl-5-carboxymethyl-1,3-thiazol-2-yl) -thiomethyl-penem-3- carboxylic acid:
HE N
about -080ГСН5 COOTBDP8
ONT
1H
MA
oSOPMp
CHS CH COONQ


Disodium salt of 2-mercapto-4- -methyl-5-carboxymethyl-1,3-thiazole (58 mg, 0.25 mmol) is added portionwise at -30 ° C to a stirred solution of tert-butyldiphenylsilyl ether (5R, 6S ) -6-lll (R) -oxyethyl - -2-methanesulfonyloxymethyl-3-carboxylic acid / (1 1 0 mg, 0.2 mmol) in anhydrous tetrahydrofuran. In 6 hours at -30 ° C and 3 hours at room temperature the mixture is partitioned between ethyl acetate and aqueous NaKCO. The aqueous layer is acidified with ice-cold 5% citric acid and immediately extracted with ethyl acetate. The hydrolysis of the tert-butyldiphenylsilyl ether is carried out with 507% aqueous acetic acid (control by thin layer chromatography). The excess acetic acid is removed under vacuum and the residue is completely neutralized with aqueous NaHCO.
By elution with water from a reverse phase column, followed by drying-freezing, the title product is obtained.
Found,%: C 36.43; H 3.67; N 5.52
C ,, OvSzNa, .H, 0
Calculated,%: C, 36.28; H 3.65; N 5.64.
PRI me R 33. Sodium salt of (5R, 6S) -6-1 (R) -oxyethyl -2- (tetrazolo-1,5-b-pyridazin-6-yl) -thiomethylpenem-3 carboxylic acid:
HE
JU S
.
COONa
S
TS
hg
4Sl
; N-if
sooma
Following the experiment) in the standard procedure described in example 4, the sodium salt (5R, b3) of (R) -oxo-ethyl -2-hydroxymethyl-2-carboxylic acid (80 mg, 0.3 mmol) is contacted with tert-buldiphenylsilylchloride - house (78 μl), metnsulfonyl chloride (24 μl), triethylamine (42 μl), and 6-myrcaptote-razolo-1,5-b-pyridazine sodium salt (57 mg, 0.35 mmol). ;; ecnJTMpon.-Jnne finally carried out the ways of mixing the solution of the crude product in tetrahydrofuran (2 ml) with 50% aqueous acetic acid (1.5 ml) for 90 minutes at room temperature. The reaction mixture was concentrated under vacuum, placed in an aqueous solution of NaHCOj and passed through a reversed phase column, eluting with water, to isolate the product,
IR spectrum (KVg)) „aks: 23440, 1765, 1605.
NMR (DjO) S ppm: 1.24 (3N, d); 3.82 (W, dd, J-1.5 and 6.1 Hz); 4.22 (1H, m); 4.66 and 4.96 (each 1H, d, Hz); 5.60 (W, d, 5 Hz); 7.68 (1H, d, 6 Hz); 8.38 (1H, d, 6 Hz).
PRI me R 34. Disodium salt of (5R, 6S) (K) -oxyethyl -2- (8-carboxitrazo-1,5-L1-pyridazin-6- -yl) -thiomethyl-3-carboxylic acid :
ZN
Sosh

r ilf
:WITH
Sosh
40
The title compound is obtained in the form of an amorphous powder (yield 27%) if in the previous example, instead of the sodium salt of 6-mercaptotetrazolo-β-G1,5-L1-pyridazine, 6-mercapto-8-carboxy-tetrazolo-tl, 5-β-pyridazine ( 74 mg, 0.4 mmol) and triethylamine (112 μl, 0.8 mmol).
R11P (D20) 5, ppm: 1.3 (3N, d); 3.9 (W. dd); 4.2 (W, m); 4.45 (2H, ABq); 5.6 (1H, d); 8.2 (IE, s).
PRI me R 35. Sodium salt (5R, 6S) -6-tl (R) -OKCH3Tmi; j-2- (8-aMH-nottetrasol-1,5-CZ-pyridazin-6-yl) - - Thiomethyl Penem-3-carboxylic acid:
R
CRG
he
COONa

five
about
0
five
0

HE
Shg
five
ILI XT
mn S
O N- COONQ
The sodium salt of (5R, 6S) -6-fl (R) - -oxyethyl-3-hydroxymethylpenem-3-carboxylic acid (80 mg, 0.3 mmol) is converted to its tert-butyldiphenylsilyl ester by stirring in for 2 h with t-butyldiphenylsilyl chloride (78 μl, 0.3 mmol) in anhydrous tetrahydrofuran. Diphenylchlorophosphate (62 µl, 0.2 mmol) and triethylamine (42 µl, 0.3 mmol) are added to the crude mixture at -20 ° C and the whole mixture is stirred for 15 minutes in the cold and 30 minutes at room temperature The solution is again cooled down and treated with a solution of 8-amino-6-mercaptotetrazolo-lll, 5-L1-pyridazine (50.5 mg, 0.3 mmol) and triethylamine (83 μl, 0.6 mmol) in tetrahydrofuran (3 ml). After stirring overnight at -20 ° C, the reaction mixture was concentrated under vacuum and partitioned between ethyl acetate and aqueous NaHCO, solution. The organic layer containing the tert-butyldiphenylsilyl ether of the title product is dried over Na SO, freed from solvent, and the residue is directly placed in a mixture of tetrahydrofuran, acetic acid, and HO (1: 1: 1.5 ml). Upon completion of the hydrolysis of the silyl ester (control by thin layer chromatography), the crude mixture is concentrated under vacuum, neutralized with help) a sufficient amount of aqueous NaHCO solution, and then purified using a reverse phase chromatography column, thus obtaining the named product as foam.
to-spectrum (KVg) V: 1760, 1660, 1625 cm.
NMR () 8 ppm: 1.30 (AH, d); 3.77 (1H, dd,, 8, and 6.5 Hz); 4.18 (W, m); 4 „55 (2H, lg s); 5.50: (1H, d, J, 8 Hz); 6, jO (IH, s).
PRI me R 36. The disodium salt of (5R, 6S) -6-ll (R) -oxy-3-2- (2-methyl-5-oxy-6-oxy-2, 5-dihydro-1, 2, 3,4-triazin-3-yl) -thiomethylpenem-3-carboxylic acid:
O N- coopNB
N
Shz.
COONa
A solution of p-nitrobenzyl ester of (5K, 6S) (I) -p-nitrobenzyloxycarbonyloxyethyl1-2-methanesulfonyl-hydroxymethyl-3-carboxylic acid (63 mg, 0.1 mmol) in anhydrous tetrahydrofuran (3 ml), cooled to - 30 C, treated with a solution of 2-methyl-3-mercapto-5-oxo-6-ox-2,5-dihydro-1,2,4-triazine (24 mg, 0.15 mmol) and triethylamine (42 μl , 0.3 mmol) in the same solvent.
After allowing to stand for 30 minutes, the mixture is allowed to warm to room temperature and then concentrated under vacuum. The residue is placed in ethyladetate, washed with water, dried (Na SO) and evaporated.
After purification by reverse phase chromatography, the obtained di-T1-nitrobenzylOe intermediate compound is dissolved in tetrahydrofuran (1 ml), intensively mixed with an aqueous solution of NH C1 (1 mol / l, 5 ml) and iron powder (0.3 g ),
Upon completion of the reaction (monitoring by thin layer chromatography), the mixture is treated with aqueous NaCO, filtered, the filtrate is washed with ethyl acetate, concentrated to a syrup, which is purified on a column (Li Chroprep rep RP-18) (water as eluant), thus obtaining named product
UV (H20) Yamak: 241 (15.340) and 302 nm (, 466),
IR (KBV) 1) MO1X: 3420, 2960, 2920 1760, 1640, 1605 cm,
NMR () 8 ppm: 1.27 (AH, d); 3.67 (311, s); 3.84 (IH, dd,, 6, and 5.9 Hz); 4.22 (IH, PI); 4.61 (2K, ABd,, 5 Hz); 5.57 (IH, d, 6 Hz).
Example 37, (5R, 6S) (K) -p-nitrobenzyloxycarbonyloxyethyl -2- (4-me-TIL-5-OXO-6-OXI-4,5-dihydro-1,2,4 p-nitrobenzyl ether - -triazin-3-yl) -thiomethylpenem-3-carboxylic acid:
OSOMRMV
0 OC02PNB
il
OH. COOpNB
S-jl-nao
0 СООРШ Шз
0
five
0
five
0
five
0
five
(5R, 6S) (K) -p-nitrobenzyloxycarbonyloxyethyl -2-hydroxymethylpenem- p-nitrobenzyl ether solution. -3-carboxylic acid (100 mg, 0.18 mmol) in anhydrous dichloromethane (10 ml) is sequentially treated at -25 ° C with triethylamine (28 μl, 0.20 mmol) and methanesulfonyl chloride (14 μl, 0.18 mmol). The mixture is allowed to warm to room temperature, then washed with a dilute solution of NaKCO, dried (Na SO) and evaporated,
The residue is dissolved in anhydrous tetrahydrofuran (5 ml), treated with a second amount of triethylamine (28 μl), and then 3-mercapto-4-me-TIL-5-OXO-6-OXI-4,5-dihydro-1, 2,4-triazine (32 mg, 0.2 mmol). After stirring for 3 hours at 0 ° C, the solvent is evaporated under vacuum and the residue is chromatographed (silica gel, ethyl acetate as eluant) to give the title product as a white solid.
IR spectrum (CHCl., Liquid film)
 max. 1 -, 1685 cm3 LNR (CDCl 3) S, ppm: 1.46 (3N, d, N); 3, A2 (3N, s); 3.97 (1H, dd,, 8 and 7,); 4.47 (2H, ABq, Hz, separation of internal lines 7 Hz); 5.07-5.47 (5H, m); .5,60 (1H, d, 7 Hz); 7.49 (2H, d, J 8.5 Hz); 7.60 (2H, d, 5 Hz); 8.16 (4H, d, 5 Hz),
Hydrolysis of the protecting groups according to the method described for Example 36 gives (5R, 6S) (K) - hydroxyethyl -2- (4-me-TIL-5-OXO-6-OXY-4,5-dphydro-1, 2,4-t riazin-3-yl) thiomethinepenem-3-carboxylic acid,
Example of p-Mptrobenzyl ether (5R, 68) -6-G1 (R) -n-nitrobenzyl33
hydroxycarbonyloxyethyl -2azol-5-yl) -thiomethyl peene acid:

OCOipNB

O NOSO CH COOpNB
one
r
COOpNB
Using p-nitrobenzyl ester (5R. 6S) (K) -p-nitrobenzyloxycarbonyl, coxyethyl-2-methanesulfonyl-, hydroxymethyl-3-carboxylic acid (63 mg, 0.1 mmol) and 2-amino -5-mercaptothiazole (20 mg, 0.5 mmol), according to the method described in Example 37, the title compound (28 mg, 42%) is obtained.
UV spectrum (EtOH) A „max: 325 nm.
IR spectrum (nudzhol) .x 3200-300, 1785, 1755, .1710 cmL
MS (FD) m / e 673 (M). For
34
(77 μl), and then chloride: methyl (41 μl). The temperature is allowed to rise to 20 ° C, the mixture is washed with water, dissolved over Na SO, and the solvent is evaporated to give an oil, which is used in the usual way for substitution reactions with nucleophilic sulfur groups, as indicated, for example, in the following examples.
A sample purified by chromatography on a short column has the following spectral properties:
UV spectrum (CHCl1) X,: 328 nm ().
IR spectrum (film) i) max 1793, 1710, 1590, 1360 and 1175 cm
II p & meper 40. Allyl ether (5R, 6S) (R) -TpeT-butyldimethylsilyloxy-istil -2- (4-methyl-5-oxo-6-oxy-4,5-dihydro-1, 2,4-triazin-3- -yl) -thiomethylpenem-3-carboxylic acid:
OTBDhS
.
ABOUT
OSOiCHs
coo
, required M, 673.
Hydrolysis of the resulting compound according to the method of Example 36 yields (5R, 6S) -6-t1 (R) -oxyethyl-1-2- (2-aminothia-) | -thiomethyl-3-carboxylic acid.
PRI me R 39. Allyl ester of (5R, 6S) (R) -tert-by-dimethylsilyloxy-istil -2-methanesulfonyloxymethyl-3-carboxylic acid:
Otbdjms

he
og
OTBDMS
O802.sng
sob
Allyl ester solution (5R, 6S) -6-Cl (K) -t-butyldimethylsilyloxyethyl3-2-hydroxymethylpenem-3-carbonic acid (200 mg) in anhydrous dichloromethane (10 ml) not containing ethanol treated at a nitrogen atmosphere with triztilamino
thirty
OTBDMS H s
35
oh soo
Cold solution of 6-hydroxy-3-mercapto-4-methyl-4,5-dihydro-1,2,4-triazin-5-one (100 mg) and triethylamine
(0.157 ml) in tetrahydrofuran
(20 ml) is added to a solution of (5R, 6S) -6-I1 (K) -t -butyl dimethylsyl-1-ethyl ethyl -2-methanesulfonyloxymethyl-3-carboxylic acid (240 mg) allyl ester (240 mg) in the same solvent, and a mixture hold overnight at about 0 ° C. The solvent is evaporated and the residue is partitioned between ethyl acetate and water.
Removal of the solvent from the dried organic extracts followed by silica gel chromatography (ethipacetate-cyclohexane) gives the title product a white.
amorphous solid.
UV spectrum (CHCI.J) XMC.KC 80 (9,103) and 321 nm (8,73-3).
IR (SNS.z) xs: 3210, 1790, 1710 and 1590 cmL
NMR (CDClg), ppm: 0.06 (6H, -s); 0.89 (9K, s); 1.22 (3N, d); 3.14-3.53 (2H, m); 3.46- (3N, s); 3.72 (1H, dd, And 4 Hz); 4.28 (1H, m); 4.50 (2H, center ABq); 4.72 (2H, m); 5.58 (1H, d, Hz) and 11.0 (1H, broad s).
PRI me R 41. Allyl ether (5R, 6S) (K) -oxy-1-2- (4-me-TIL-5-OXO-6-OXY-4,5-dihydro-1,2,4- triazin-3-Sh1) -thiomethylpenem-3-carboxylic acid:
OTBDMS
Q / b-1S-b, l
soo
L i-v
he
-b-jc
 x ... d N- VOH 0 sob bn,
A solution of (5R, 6S) -6-itl (K) -t-butyldimethylsilyloxyethyl 3 allyl ester 2- (4-methyl-5-oxo-6-hydroxy-4,5-dihydro-1,2,4-triazine) 3-yl) -tis-methylpenem-3-carboxylic acid (130 mg) in tetrahydrofuran (3 ml) is treated with acetic acid (0.14 ml) and tetrabutylammonium fluoride trihydrate (228 mg). After 18 h at room temperature, the mixture is evaporated to dryness under vacuum and fractionated on a silica gel column (5 cm, cm Merck 60 HR 230-400 mesh). Elution with pure ethyl acetate and then 95: 1 ethyl acetate / ethyl alcohol gives the title product.
UV Spectrum (EtOH) I 251 (7.840) and 318 nm (, 770).
MIC (CHCl), c; 3400 br, 1785, 1710 br cm.
NMR (COClS) & ppm: 1.34 (3N); 3.44 (3N, s); 3.78 (1H, d, and 6.5 Hz); 4.22 (1H, m); 4.47 (2H, broad s); 4.72 (2H, m); 5.25 and 5.40 (each 1H, wide doublet); 5.62 (1H, d, Hz); 5.96 (1H, m) and 1.1 (1H, broad singlet).
PRI me R 42. Sodium salt of (5R, 6S) -6-tl (R) -oxyethyl l-2- (4-me-TIL-5-OXO-6-OXI-4,5-dihydro- 1 -, 2,4-triazin-3-yl) -thiomethylpenem-3-carboxylic acid:
W S N,
he
l
N-,
C02Na well
HE

Triphenylphosphine (10 mg) and tetrakis- (triphenylphosphine) palladium (0) (10 mg) are added to a solution of (5R, 6S) allyl ester (R) -oxo-ethyl -2- (4- -methyl-5-oxo-6 -oxy-4,5-dihydro-1, 2,4-triazin-3-yl) -thiomethylpenem-3-carboxylic acid (60 mg) in a mixture of 2: 1 tetrahydrofuran and dichloromethane (1.5 ml) . After stirring the IB, a 0.5 mol / L sodium ethyl hexanoate solution in a 1: 1 tetrahydrofuran / dichloromethane mixture (0.1 ml) is added for 30 minutes.
The mixture is stirred for several minutes and then left to stand for 1 hour at. The precipitated solid was repeated by centrifuging and washing with fresh dichloromethane, and then it was dried under vacuum to obtain 56 mg of the title product.
UV spectrum (F, n) 304 nm (8330).
Zh-spectrum (KBr) V «,: 3420, 2960, 2920, 1760, 1700, 1610 and 1580 cm ×

EXAMPLE 43 Allyl (5R, 6S) -6-t1- (R) -tert-butyldimethylsilyloxyethyl -2- (2-methyl-5-oxo-6- -tert-butyldiphenylsilyloxy-2.5 -di-hydro-, 2,4-triazin-3-yl) -thiomethyl-penem-3-carboxylic acid:
he
OTBDMS ES. N OTBDPS
coo
37
t-
A. A solution of 2-methyl-3-mercapto-6-β-oxy-2.5-DIGIDRO-1,2, A-triazin-5-β-one (0.8 g) in anhydrous tetrahydrofuran (25 ml) is stirred for 30 min with triethylamine (0.835 ml) and tert-butyldiphenylsilyl chloride (Ij53 ml). The reaction mixture is partitioned between 1% aqueous Hbw NaHCO solution and ethyl acetate.
The solvent is removed from the dried organic layer to give a residue, which is crystallized by trituration with light gasoline to give 2-methyl-3-mercapto-6-tert-butyl diphenylsilyloxy-2,5-dihydro-1,2,4-triazine. 5-he (1.34 g) t.kip 135 ° C (with decomp.).
UV spectrum (CHC1e) y1 „: 27fi (e 20.820) and 320 Sh (4.460) nm.
IR Spectrum (SNS). ,,: 1720, 1580 cm-.
NMR (CDCl 3) ppm: 1.1 (9H, S); 3.4 (3N, S); 7.2-7.7 (UN, m); 9.9 (1H, lg s).
B. A solution of triphenylphosphine (472 mg) in anhydrous distilled tetrahydrofuran (12 ml) is treated at 0 ° C with ethyl azodiocarboxylic ester (282 μl, dissolved in the same solvent). After stirring for 1 hour with this solution, the solution of the product obtained in step A (630 mg) and the (5R, 6S) -6 -) (R) -t-butyldimethylsilyloxyethyl 1 -2- - - hydroxymethyl-P-carboxylic acid (600 mg) in anhydrous distilled tetrahydrofuran1 (6 ml).
Shortly after the end of the addition, the reaction is completed (monitored by thin layer chromatography, Sic) Ethyl acetate / Cgliyrj (1: 2); the solvent is removed, and the unpigmented material is freed from a certain amount of polar impurities by flash chromatography (SiO ethyl acetate-diclomexan), thus obtaining 1 g of the title product.
UV spectrum (CHCI3) I. „„, from 333 nm.
five ,
1238
4.20 (1H, m); 4.65 (4H, m); .5.15-5.50 (2H, m); , 54 (1H, d); 5.70-6.15 (W, m).
PRI me R 44. Allyl ether (5R, 6S) (K) -oxyethyl -1-2- (2-me-TIL-5-OXO-6-OXY-2,5-dihydro-1,2,4- triazin-3-yl) thiomethyl penem-3-carboxylic acid:
t5
0
OTBDMS H S
in
N OTBDPS


The bis-Silylated material obtained in Example 50 (1 g) dissolved in anhydrous tetrahydrofuran () was stirred for 22 hours at room temperature in the presence of acetic acid (0.76 ml) and tetrabutylammonium fluoride trihydrate ( 1.26 g). The solvent is removed under vacuum, the residue is placed in a small amount of water ($ 10 ml) and passed through a reverse phase column (diameter 2 cm, height 10 cm Merck Li. Chroprep RP-18), eluting first with water and then with HgO / EtOH 4: 1, and finally, a mixture of HjO / EtOH 2: 1. The named product is obtained from the latter fractions by removing ethanol, followed by drying-freezing (350 mg).
IR spectrum (СНС., Film). : 3400 wide, 1750 1700 wide cm
PRI me R 45. Disodium salt of (5R, -6S) -Cl (R) -oxy-3-3- (2- -methyl-5-oxo-6-hydroxy-2.5-dihydro -1,2 , 4-triazin-3-yl) -thiomethylpenem-3-carboxylic acid:
Zh-spectrum (film) 1705, 1665 cm
1787,
NMR (ppm: among other things, 3.30 (3N, s); 3.66 (1H, dd);
TH s 4VoH
- jTsn N S.
ABOUT
COO
39
NZS
COONu N
(5R, 6S) - (R) -oxy-ethyl-J-2- (2-methyl-5-OXO-6-OXI-2.5-DIHYDRO-1,2,4-triazin-3-yl allyl ester solution ) -thiomethylpenem-3-carboxylic acid (300 mg) in a mixture of tetrahydrofuran (5 ml) and dichloromethane (2 ml) is treated with stirring with triphenylphosphine (30 mg) and tetrakis- (triphenylphosphine) palladium (0) ( 30 mg), a solution of 0.5 mol / l sodium ethylhexanoate in a 1: 1 mixture of tetrahydrofuran and CH SG (2.86 ml) is added shortly thereafter. The precipitate is collected by centrifugation, triturated in CH C and again centrifuged (twice), then dissolved in a small amount of water and immersed through a reverse phase column (Merck Li. Chroprep RP-18), eluting with distilled water, fractions containing product (eluent CHC1j (CH jOH) HCOOH 90:15:10, R.0.3) are collected and evaporated, getting a named product. UV spectrum | 1 .211 and 308 / shoulder,
nm
G-spectrum (KVg): 3420, 2960, 2920, 1760, 1640 and.
NMR () 200 MHz. $, Ppm: (device) 1.25 (ЗН, d); 3.65 (3N, s); 3.82 (1H, dd,, 6, and 5.9 Hz); 4.20 (1H, m); 4.59 (2H, ABq, 5 Hz, internal line separation 14.9 Hz) 5.55 (W, d, 6 Hz).
In a similar way, the sodium salt of (5R, 6S) -6-0 (P) -oxo-ethyl-2- (1,2,4-triazol-5-yl) -thiomethyl-3-carboxylic acid is obtained.
UV (H, 0) L „„,: 314 nm.
IR (KBV) L: 1765 and 1620 (W)
iМлкс
cm .
II p and measure 46. Using the corresponding precursors as starting materials and following the experimental procedure described in examples 39-42 (method A in the table), or the method described in examples 43-45 (method B in the table) the compounds listed in Table 2 are obtained. one.
PRI me R 47. Following the procedure similar to that described in Examples 46 to 49, the following compounds are synthesized: (5R, b8) (R) -oxoethyl
- O 15 20 p 25 30
,
- 35; ) 40
1240
2- (1-methylimidazol-2-yl) -thiomethyl-pemen-3-carboxylic acid, isolated as the sodium salt.
UV (N /) A „„,: 315 nm.
roiR (200 MHz,) 5, ppm: 1.21 (3N, 3 Hz); 3.72 (3N, s); 3.76 (1H, dd,, 4, and 6 Hz); 4.13 (2H, ABq, Hz, internal line separation 36 Hz); 4.14 (1H, m); 5.51 (1H, d, 4 Hz); 7.04 and 7.21 (each 1H, d, 3 Hz).
 (5R, 6S) (R) -oxyethyl} -2CHl- - (1, 2,3,4-tetrazol-5-yl) methyl-1,2,3, 4-tetrazol-5-yl1-thiomethyl-penem-3 - -carboxylic acid, in the form of sodium salt; UV spectrum (H, 0) 2.56 and 314 nm.
Replacing sodium ethyl hexanoate with a molar excess of acetic acid, these compounds are isolated as free acids. In addition, the following compounds are obtained: (5R, 6S) - -6-11 (R) -oxyethyl -2- (3-amino-l, 2,4-triazole- (5-yl) -thiomethyl-3-cage - booms acid; UV spectrum (CO) a „: 262 and 311 nm and (5R, 6S) -ll (R) - -oxyethyl 2- (1,2, 3-thiadiazol-5-yl) -thiomethylpenene -3-carboxylic acid. UV spectrum (H, 0) X ": 330 nm. MS (FD) m / e 345 (M), M O requires M 345.
PRI me R 48. Allyl ether; (5R, 6S) -6-Il (R) -oxy diethyl -2- (G, 2,4-triazol-5-yl) -thiomethylpenem-3-carboxylic acid:
OTBDMC LR S
about 5ГГ-.,
.
СОО-СНтСН СН2 None l s
--H-Yy-ti-;.
 i g
COO-CH2-CH CH
Allyl ester solution (5R, 6S) - -6-1 (Рч.) - tert-butyldimethylsilyloxy- (1,2,4-triazol-5-yl) thiomethyl-penem-3-carbonic acid (0.380 g), in tetrahydrofuane (8 ml) is treated with acetic acid (0.5 ml) and tetrabutylammonium fluoride trihydrate (0.69 g) until the starting material disappears (control by thin layer chromatography) (1424 h). The reaction mixture is evaporated in vacuo and then chromatographed (column, eluent ethyl ethyl acetate / cyclohexane), thus obtaining the title compound, IR spectrum (CHCl 3 film): 3380 wide, 1785, 1715 cm.
P 49 p. Sodium salt of (5R, b8) -6-P (K) -oxyethyl} -2- (1, 2,4-triazol-5-yl) -thiomethylpenem-3-carboxylic acid:
NLD
n
SOOCH2-C1: CH2
HE
o / -isr-4
ISf "IspN
Sosha
 The allyl ester solution obtained in Example 55 (0.2 g in tetrahydrofuran (1 ml) was sequentially treated with triphenylphosphine (0.07 g) and tetrakis- (triphenylphosphine) palladium (0) (0.07 g), and then after a few minutes with a 0.5 mol / L sodium ethyl hexanoate solution in a 1: 1 mixture of tetrahydrofuran / / dichloromethane (2.1 ml). After stirring for 15 minutes, ethyl ether was added to precipitate the title compound as a yellowish powder, which is collected by filtration, washed several times with dichlodrmethane and dried by vacuum, UV spectrum (H „0): 314 nm; IR spectrum
(KBr) vl,
1765 and 1620 (wide)
cm
PRI me R 50. Acetoxymethyl ester (5R, 6S) (R) -oxyethyl -2- - (1-metip-1,2,3,4-tetrazol-5-yl) - | -thiomethylpenem-3- carboxylic acid:
hh-j,
DZ

.
COiNa SNg
Nn
DDI I
CHi С02СН20СОСН
K-, .N
Q II I
S-4-j biz
s sndeosn
at
five
0
five
0
five
0
five
0
five
A. A solution of the sodium salt of (5R, 6S) - (K) -oxyethyl -2 - (- methyl-, 2, 3,4-tetrazol-5-yl) -thiomethylpene-3-carboxylic acid (3.1 g) in anhydrous dimethylformamide (25 ml), incubated overnight in the presence of bromomethyl acetate (2.2 g). After another 2 hours at room temperature, the reaction mixture is partitioned between brine and ethyl acetate. After several washes with brine, the organic phase is dried and evaporated to a residue, which is triturated with ethyl zfir with light gasoline, thus obtaining the title compound as a white powder.
IR spectrum (KVg): 1795, 1760, 1720 cm H
NMR Dacetone d-6) & ppm (among other things): 1.25 (3N, d); 2.06 (3K, s); 3.75 (IHi dd); 5.83 (2K, ABq); 5.69 (IH, d, 5 Hz).
B, Solution of acetoxymethyl ester (5R, B5) (K) -t-butyl-Dimethylsilyloxy-istil -2- (1-methyl--1,2,3,4-tetrazol-5-yl) -thiomethyl-pemen-3-carboxylic Acids (1 g), prepared as described in Example 18, are stirred in anhydrous tetrahydrofuran for 20 hours at room temperature in the presence of acetic acid (I ml) and tetrabutylammonium fluoride (1.5 g). By removing the solvent and distributing the residue between ethyl acetate and water, followed by evaporation, the evoked compound is obtained.
P. Example 50. Reaction of (5R, 6S) (R) -TpeT-α-butyl dimethylsilyloxyethyl -2-hydroxymethyl-penem-3-karboxylic acid allyl ester with the corresponding heterocyclic thiol and the previously prepared triphenylphosphine complex and diethyl - an azodicarboxylate followed by 1; by successively cleaving the silyl-hydroxy or allyloxy-protecting groups according to the procedure shown in the examples, a two-potassium salt is obtained
(5R, 65) (E) -oxyethylZ-2- (5-carboxymethylthio-1,3,4-thiadiazol-2-yl) - -timeter lpenem-3-carboxylic acid, IR spectrum. (KVg) “Ax: 3380, 1755, 1610 cm W 1P (DjCOS, ppm: 1.25 (ZN, d); 3.85 (1H, dd-, 5 and 6 Гп) 3.97 (2H, s) ; 4.2 (IK, m); 4.55 (2H, s); 5.57 (IH, -d, 5 Hz).
The compounds of formula (I) are highly antibacterial active. With both animals and humans, against gram-positive and gram-negative bacteria, such as staphylococci, streptococci, diplococci, Klebsiella, Escherichia coll, Proteus Mirabilis,. Salmonella, Shigella, Hacmophilus and Neisseria. They also exhibit high activity against resistant beta-lactase-producing microorganisms, such as Klebsiella acrogenes 1082 E, Escherchia coli TEM, Enteraba ctes cloacal P 99, indololol-. Proteus, etc., as well as against Pseudomonas aeruginosa ttams.
For example, (5R, 6S) (K) -oxy-ethyl -2- (tetrazolo C 1., 5-b liridazin-6-nl) -thiomethylpenem-3-ka; 1 boronic acid is particularly active: against gram-positive bacteria,
in particular, for the sodium salt of the indicated compound, the minimum inhibitory concentration (MIC) is 0.002 µg / ml to suppress Streptococcus pyogenes pneumonial and 0.004 mcg / ml to suppress the non-producing penicillinase-producing strains of Staphylococeus aureus. Disodium salt of (5R, 6S) -6-1 (K) -oxyethyl -2- (2-methyl-5-oxo-6 hydroxy-2,5-dihydro-1,2,4-triazin-3-yl) thiomethylpenem -3-carboxylic acid, for example, has a particularly strong activity against gram-negative bacteria, such as, for example, Escherichia coli 1507 E, Es.cherichia coli TEM, Klebsiella pneumonial ATCC 10031 and Proteus vulqris x 20.
Especially active against both gram-positive and gram-negative bacteria (5R, 6S) -6-Ll (R) - hydroxyethyl -2-11- (2-aminocarbonylethyl) - 1,2,3,4-tetrazol-5-yl - thiomethyl penem-3-carboxylic acid, (5R, 6S) (R) -oxyethyl-2- (5-carboxymethylthio-1,3,4-thiadiazol-2-yl) thiomethylPenem-3-carboxylic acid and (5R, 6S ) -6-C1 (R) -oxyethyl1-2- (1-methyl-1,2,3,4-tetrazol-5-yl) -thiomethyl1-penem-3-carboxylic acid.
Due to its high antibacterial activity against gram-positive and against gram-negative bacteria, the proposed compounds can be used to treat infections caused by these microorganisms, such as infections of the respiratory tract, such as bronchitis, bronchopneumonia, pleurisy; infections of the liver, gallbladder and abdomen, for example, septicemi; urinary tract infections, such as pyelonephritis, cystitis; obstetric and gynecological infections, for example, cerpicitis, endometritis; infections of the ear, nose and throat, for example, otitis, sinusitis, parotitis.
The toxicity of the proposed compounds is completely negligible, so they can be safely used in therapy.
They can be administered to humans or animals in various forms, for example, orally in the form of tablets, capsules, drops or syrups; rectally in the form of suppositories; parenterally, for example, intravenously or intramuscularly (in the form of solutions or suspensions), with intravenous administration preferably in an emergency; by inhalation in the form of aerosols or solutions for nebulizers; intravaginal in the form of, for example, a bougie; or locally in the form of lotions, creams and ointments. Pharmaceutical or veterinary compositions containing the proposed compounds can be prepared using known carriers or diluents, for example, water, gelatin, lactose, starches, mani stearate, talc, vegetable oils, cellulose, and the like. You can use daily doses in the range of 1 - 100m per kg of live weight, depending on. type of animal belly. The exact dose depends on the age, weight and condition of the patient and on the frequency and method of administration. Preferably parenteral administration of the proposed compounds. In this case, the compound can be administered, for example, to an adult in an amount of 100-200 mg per dose, preferably 150 mg per dose, administered 1-4 times per day, dissolved in a suitable solvent, such as sterile water or lidocaine hydrochloride solution.
45
intramuscular injection, physiological saline solution, dexrose solution or conventional intravenous fluids or electrolytes for intravenous injection. The proposed compounds can be used as antibacterial agents prophylactically, for example, in cleansing or disinfectant compositions, at a concentration of about 0.2 to 1 wt.%, Suspended or dissolved, usually in an inert anhydrous or aqueous form. rinsing or spraying media. They can also be used as nutritional supplements in animal feed.
The data in the following table 2 show the pharmacological properties of the compounds of the formula T (their respective codes are indicated) in comparison with the known compound - 7-p-cyano-ethylene (cis) -thioadetamido-3- (tetrazolo 1,5-b pyridazine -8-amino-6-yl) -thiomethyl-3-cephem-4-carboxylic acid.
Codes.connections table. 1 and 2 are described as follows: FCH 23058 Potassium (5R, B5) -6-G (1K) -oxyethyl-2- (1H-I, 2, 3,4-tetraeol-5-yl) -thiomethyl-penem-3-carbo - Xylate. FCE 22055 Sodium (5R, 6S) -6 (1K) -oxyethyl -2- (I-methyl-I, 2,3,4-tetrazol-5-yl) -thiomethylpenem-3-carboxylate.
FCE 22752 (5R, 6S) -6- (lR) -oxxy. (1-Carboxymethyl-1,2,3,4-tetrazol-5-yl) -thiomethylpenem-3-carboxylic acid, distillate salt.
FCE 22753 Disodium salt of (5R 6S) -6- (lR) -oxyethyl-2- (1-carboxyethyl-1,2 3,4-tetrazol-5-yl) -thiomethylpene-3-carbonic acid FCE 22988 Sodium (5R, 6S) -6f (lR) -oxyethyl -2-l- (2-aminocarboxyethyl) - 1,2,3,4-tetrazol-5-sh1 thiomethylpenem-3-carboxylic acid. FCE 22862 Sodium (5R, 6S) -6C (1R) -oxyethyl -2-1- (2-cyanoethyl) -1,2,3,4
YU
15
,
20
- jq

Q
. .

FCE 22859
AM 5417-4A
FCE 23127
BA5456-41
FCE 22923
AM 544J-91A
FCE 23077
35
FCE 22682
FCE 22842
50
FCE 22864
FCE 22954
46
tetrazol-5-yl-thiomethylpenem-3-carboxylate.
(5R, 6S) -6-1 (1 R) -OKCH-ethylZ-2-1- (2-dimethyl-aminoethyl) -1,2,3,4-tetrazol-5-yl-thiomethyl-penem- 3-carboxylate. Potassium (5R, 6S) -6- / r (lR) - hydroxyethyl -2- (1H-1,3,4-triazol-2-yl) -thiome-tylpenem-3-carboxylate Potassium (5R, 6S) - 6-r (lR) - hydroxyethyl -2- (4-3 tyl- 1,2,4-triazol-3-yl) thiomethylpenem-3-carboxylate.
(5R, 6S) -6- (lR) -OKCH- (3-amino-1H-1,2,4-triazol-5-yl) -thiomethylpenem-3-carboxylic acid Potassium (5R, .6S) - 6- (lR) -oxyethylZ-2- (5-amino-1,3,4-thiadiazol-2-yl) thiomethylpenem-3-carboxylate
The two-potassium salt of 5R, 6S) -5- (1R) -oxyethyl-2- (5-carboxymethylthio-1, 3,4-thiadiazol-2-: yl) -thiomethylpenem-3-carboxylic acid. Sodium (5R, 6S) -6-I1R) -oxyethyl -2- (1-methylimidazol-2-yl) -thiomethylpenem-3-carboxylate.
Sodium (5R, 6S) -6- t (1R) -oxyethyl -2- (4-methyl-5-oxo-6-hydroxy-- 4,6-dihydro-1,2,4-triazine-3- or (yl) -thiomethylpeneme.-3-carboxylate. Disodium salt of (5R, 6S) -6- (lR) -oKCH- (2-methyl-5-ca-CO-6-OXY-2,5-dihydro-1,2,4-triazin-3-yl ).
Thiomethyl Penem-3-carboxylic acid.
Sodium (5R, 6S) -6 - {:( lR)
test-2- (6-marks
Sipyrazin-2-yl) -thiomethylpenem-3-carboxylate.
Sodium (5R, 6S) -6- (lR) - hydroxyethyl1-2- (tetrazo471299512
lo 11,5-b pyridazin-6-yl) -thiomethylpenem-3-carboxylate. 22846. Sodium (5R, 6S) -6 .C (1K) -oxyethyl -2- (8-5 aminetotetrazoloE1, pyridazin-6) -thiomethyl-penem-3-carboxylate.

权利要求:
Claims (3)
[1]
1. A method of producing substituted penem-3-carboxylic acid derivatives or their esters, or their salts with alkali metals
ORi
0
rjr s-het cool ,,
Het is 1,3,4-thiadiazol-2-yl, substituted in position 5 with an amino group or a carboxymethylthio group, in which the carboxy group can be in the form of a salt with an alkali metal, 1,2, 3-thiadiazole-530
3-amino-1,2,4-triazol-5-yl, 4-ethyl-1,2,4-triazole 3-yl, 1,3,4-triazol-2-yl, 2-aminothiazol-5 -yl, thiazole 2-yl, disubstituted with methyl and carboxymethyl, in which the carboxy group can be in the form of a salt with an alkali metal, 1-methylimidazol-2-yl, tetrazol-5-yl, free or substituted in position 1 by methyl, cyano ethyl, aminocarbonylethyl, dimethylaminoethyl, tetrazol-5-ylmethyl, carboxymethyl, carboxyethyl, sulfomethyl or sulfoaminoethyl, in which the carboxy or sulfo group can be in the form of an alkali metal salt, 6-labels of sipyrazin-2-yl, 2 -met L-5-OXO-6-OXI-2,5-dihydro-1,2,4-triazin-3-sh1 or 4-methyl-5-oxo-6-hydroxy-4,5-di-hydro-1, 2,4-triazin-3-yl, in which the hydroxy group may be in the form of a salt with alkali48
or tetrazo-, 5-L1 1 shridazin-6-yl, unsubstituted or substituted in position 8 by an amino or carboxy group, the carboxy group may be in the form of a salt with an alkali 1 metal; R is a hydrogen atom or a protecting group selected from p-nitrobenzyloxycarbonyl and tert-butyldimethylsilyl; Rn is a hydrogen atom or a protecting group forming an ester, such as p-nitrobenzyl, acetoxymethyl, allyl or tert.-butyldcmethylsilyl, or an alkali metal
characterized in that
compound of general formula II
QR,
L S n.
0
BUT
CH2-Z COORo
where R has the indicated meanings; R is a protective, ester-forming group or alkaline
five
0
metal;
Z is a hydroxy group, is esterified as a reactive ester with a sulfonic acid or diarylphosphoric acid, or a hydroxy group as a reactive complex with a compound of trivalent phosphorus and C - Cg is an alkyl ester of azodicarboxylic acid, or an hydroxy group as a reactive - capable mixed acetal - 5,
subjected to interaction with the compound of the formula III
Het - H,
where Het has the indicated values, Q or -c with its alkali metal salt, in an inert organic solvent medium, if necessary in the presence of a base at a temperature of from -70 ° C to room temperature and 5 target product is isolated, where is the protective group forming the corresponding ester, or alkali metal, - or, if necessary, convert it to the target product, where R | a hydrogen atom, a deprotection group and, if necessary, a target product, where R j is a hydrogen atom, is transferred to the target product, where the alkali metal, and / or, if necessary, the target product, where the corresponding protective group, is t in the target product, where R is a hydrogen atom.
[2]
2. The method of claim 1, which differs from the fact that, as a compound of the general formula II, where Z is a hydroxy group, is esterified in cation 1H S
- y-S-Hel
SOHSh
ABOUT
FCE 22753
FCE 22859
FCE 22734
F
312
de-reactive ester with a sulphonic acid; its ester is taken with mETanesulfonic, p-toluenesulfo, trifluoromethanesulfo- or p-bromobenzenesulfonic acid.
[3]
3. The method according to claim, characterized in that, as a compound of general formula II, where Z
hydroxy group as reactive mixed acetal, take its acetal with neopentyl alcohol and dimethylformamide.
Table s
in the gfimer 45
Same as in example 46
3080
2960 2850 1605
1.29 (3N, d)
2.93 (6H, S)
3.73 (2H / 2H, t)
3.88 (1H, dd J-2 and 4.5 Hz)
4.25 (W, m)
4.57 (2H, ABo)
4.90 (2H, t)
5.64 (1H, d J «2 Hz)
1.24 (3N, d)
3.82 (1H, dd. J-i.5 and 6.1 Hz)
4.22 (1H, m).
4.66 and 4.96 each H, d, J-12 Hz)
5.60 (1H, d) J -1.5 Hz 7.68 and 8.38 each 1H, d, 6 Hz)
 During the synthesis, the carboxyl group of the heterocyclic thiol is eatiyat in the form of its aplyl ester.
Isolated as an internal salt with 3-penecarcaroxylate aioi. Isolate as potassium salt using potassium ethylhexanoate.
53
12.9951254
table 2

类似技术:

---

公开号 | 公开日 | 专利标题

---

SU1299512A3|1987-03-23|Method for producing substituted derivatives of penem-3-carboxylic acid or tehir esters,or tehir salts with alkali metals

---

CS208747B2|1981-09-15|Method of making the7-|acetamido/cefalosporan acids and derivatives thereof

---

KR900000934B1|1990-02-19|Process for preparing b-lactam antibiotics

---

JPH09511738A|1997-11-25|Cephalosporin antibiotics

---

HU183236B|1984-04-28|Process for producing new 6-beta-hydroxyalkyl-penicillanic acid derivatives

---

SU904524A3|1982-02-07|Method of preparing unsaturated derivatives of 7-acylamido-3-cephem-4-carboxalic acid or their esters or their alkaline metal salts

---

RU2143435C1|1999-12-27|Beta-lactams

---

AU614984B2|1991-09-19|7-acylaminocephalosporin derivatives

---

FI82471B|1990-11-30|FOERFARANDE FOER FRAMSTAELLNING AV FARMAKOLOGISKT AKTIVA 6-METYLENPENEMDERIVATER.

---

JPH0559066A|1993-03-09|Thioalkylthiocephalosporin derivative

---

HU186289B|1985-07-29|Process for preparing 7-/cyylisted!-guanidino-cef-3-em compounds

---

KR920008945B1|1992-10-12|Process for preparing antibiotic compounds

---

US4537886A|1985-08-27|β-lactam antibacterial agents and compositions containing them

---

GB2118181A|1983-10-26|Substituted penem derivatives and new process for their preparation

---

EP0201206B1|1990-07-25|Penem derivatives

---

KR900008552B1|1990-11-24|Process for the preparation vinylthio acetamido-oxacepalosphorine derivatives

---

US5073550A|1991-12-17|Cephalosphorins with sulfur-containing oxyimino side chain

---

HU194891B|1988-03-28|Process for production of 6-/trisubstituated-methil/-penicillane acid and its derivatives

---

US5362724A|1994-11-08|Thioalkylthio carbacephalosporin derivatives

---

AU718495B2|2000-04-13|Isooxacephem-derivatives

---

US4172891A|1979-10-30|Cephalosporins

---

EP0249170A2|1987-12-16|Cephem compounds, their production and use

---

Nannini et al.1981|CEPHALOSPORINS. II SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF NEW 7-VINYLENETHIOACETAMIDO AND THIOACRYLAMIDO CEPHALOSPORINS

---

GB2162185A|1986-01-29|New process for preparation of substituted penem derivatives

---

RU2079498C1|1997-05-20|Penem compounds, their pharmaceutically acceptable salts, method of their synthesis and pharmaceutical composition

同族专利:

---

公开号 | 公开日

---

HU194888B|1988-03-28|

---

YU79883A|1985-12-31|

---

FR2524889B1|1986-01-10|

---

US4577016A|1986-03-18|

---

FR2524889A1|1983-10-14|

---

IE54940B1|1990-03-28|

---

ES528017A0|1985-06-16|

---

KR840004434A|1984-10-15|

---

SE8301924L|1983-11-04|

---

ZA832385B|1983-12-28|

---

SE454176B|1988-04-11|

---

DK153583A|1983-10-09|

---

PH21161A|1987-08-05|

---

ES8506022A1|1985-06-16|

---

SE8301924D0|1983-04-07|

---

AU1317883A|1983-10-13|

---

DE3312393A1|1983-10-13|

---

CA1269364A|1990-05-22|

---

FI77866C|1989-05-10|

---

IL68307A|1986-12-31|

---

CH655933A5|1986-05-30|

---

ES521277A0|1984-06-16|

---

NL8301169A|1983-11-01|

---

PT76506A|1983-05-01|

---

DK153583D0|1983-04-06|

---

NO842177L|1983-10-10|

---

IL68307D0|1983-07-31|

---

NO831160L|1983-10-10|

---

AU563030B2|1987-06-25|

---

FI77866B|1989-01-31|

---

CS235317B2|1985-05-15|

---

PT76506B|1986-02-06|

---

ATA119483A|1986-05-15|

---

ES8405798A1|1984-06-16|

---

FI831148A0|1983-04-05|

---

LU84738A1|1983-11-17|

---

BE896401A|1983-10-07|

---

IE830794L|1983-10-08|

---

US4729990A|1988-03-08|

---

GR77451B|1984-09-24|

---

JPS58185591A|1983-10-29|

---

IT1212083B|1989-11-08|

---

NZ203788A|1986-06-11|

---

FI831148L|1983-10-09|

---

YU45884B|1992-09-07|

---

IT8320495D0|1983-04-07|

---

AT381943B|1986-12-10|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US4301074A|1977-11-17|1981-11-17|Merck & Co., Inc.|6--2-substituted-pen-2-em-3-carboxylic acid|

---

EP0003960B1|1978-02-02|1983-06-29|Ciba-Geigy Ag|6-substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them|

---

US4182711A|1978-04-27|1980-01-08|Bristol-Myers Company|Antibacterial agents of the β-lactam type|

---

US4331677A|1978-11-24|1982-05-25|Farmitalia Carlo Erba S.P.A.|7-Oxo-4-1-aza-bicyclo-[3,2,0]-heptane derivatives|

---

JPS5625110A|1978-12-18|1981-03-10|Bristol Myers Co|Antibacterial|

---

US4282150A|1978-12-18|1981-08-04|Bristol-Myers Company|2,6-Disubstituted penem compounds|

---

US4272437A|1978-12-18|1981-06-09|Bristol-Myers Company|Antibacterial agents, and 4-thio azetidinone intermediates|

---

EP0013067A1|1978-12-22|1980-07-09|Beecham Group Plc|Bicyclic beta-lactam antibacterial agents, their use in pharmaceutical compositions, processes for their preparation and intermediates for use in such processes|

---

GR73623B|1979-02-24|1984-03-26|Erba Farmitalia|

---

ZA80993B|1979-02-24|1981-02-25|Erba Farmitalia|-lactam-containing antibacterial agents and -lactamase inhibitors and preparation thereof|

---

US4269771A|1979-04-06|1981-05-26|Farmitalia Carlo Erba|Total synthesis of 7-oxo-4-thia-1-azabicyclo-[3,2,0]-heptane-2-carboxyl derivatives useful as β-lactamase inhibitors and antibacterial agents|

---

US4386029A|1979-10-29|1983-05-31|Beecham Group Limited|Process for the preparation of antibiotics|

---

US4482565B1|1980-02-22|1987-11-03|

---

US4558042A|1981-05-06|1985-12-10|Farmitalia Carlo Erba S.P.A.|β-Lactam-containing antibacterial agents and β-lactamase inhibitors|

---

JPS57179190A|1981-04-27|1982-11-04|Yamanouchi Pharmaceut Co Ltd|Novel penem compound|

---

JPS588084A|1981-07-08|1983-01-18|Takeda Chem Ind Ltd|-substituted--penem-3-carboxylic acid derivative and its preparation|

---

AT379399B|1981-12-11|1985-12-27|Erba Farmitalia|METHOD FOR PRODUCING OPTICALLY ACTIVE PENEMAS|

---

GB2118181B|1982-04-08|1986-07-30|Erba Farmitalia|Substituted penem derivatives and new process for their preparation|

---

US4435412A|1982-11-29|1984-03-06|Schering Corporation|5R,6S,8R-2--6-penem-3-carboxylic acid|

---

AU563157B2|1982-12-08|1987-07-02|Farmitalia Carlo Erba S.P.A.|2-thiacephems and penems derivatives|

---

JPS59152387A|1983-02-10|1984-08-31|Shionogi & Co Ltd|Novel penem compound|JPH0532367B2|1983-08-01|1993-05-14|Nihon Nohyaku Co Ltd|

---

GB8416652D0|1984-06-29|1984-08-01|Erba Farmitalia|Penem derivatives|

---

GB8416651D0|1984-06-29|1984-08-01|Erba Farmitalia|Penem derivatives|

---

GB8509180D0|1985-04-10|1985-05-15|Erba Farmitalia|Penem derivatives|

---

US4663451A|1985-05-09|1987-05-05|Farmitalia Carlo Erba S.P.A.|Process for the synthesis of penems and penams|

---

CA1339860C|1985-06-17|1998-05-12|Tsunehiko Soga|Derivatives of penem|

---

GB8605549D0|1986-03-06|1986-04-09|Erba Farmitalia|Penem derivatives|

---

US4992543A|1988-10-19|1991-02-12|Pfizer Inc.|Penem derivatives|

---

US5191075A|1988-10-19|1993-03-02|Pfizer Inc|Process for the preparation of penems|

---

US6414156B2|1998-10-21|2002-07-02|Bristol-Myers Squibb Company|Process for preparing azacycloalkanoylaminothiazoles|

---

US6392053B2|1999-12-15|2002-05-21|Bristol-Myers Squibb Company|Process for preparing arylacetylaminothiazoles|

---

US6040321A|1997-11-12|2000-03-21|Bristol-Myers Squibb Company|Aminothiazole inhibitors of cyclin dependent kinases|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

GB8210410|1982-04-08|

---